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The exocyst is a complex of proteins classically known for its role in tethering 
secretory vesicles during exocytosis, but it has since been shown to participate 
in a whole host of other cellular processes. Several human patients have been 
discovered in whom mutations in the exocyst appear to cause disease, but the 
underlying mechanisms are still poorly understood. This highlights an urgent 
need to better characterise these proteins. The exocyst complex is conserved in 
the fission yeast Schizosaccharomyces pombe, which is an ideal model 
eukaryote in which to examine conserved biological mechanisms. In this study, I 
used GFP-Trap combined with qualitative proteomics to reassess the role of 
exocyst component Sec8. Unexpectedly, this uncovered putative novel 
associations with both the nuclear envelope and the mitochondrial envelope. 
Using live-cell imaging, I further showed that cells expressing mutated Sec8 
displayed altered mitochondrial morphology and a significant reduction in 
mitochondrial fusion. This indicates that Sec8 is somehow involved in 
mitochondrial distribution and dynamics, a role which has not been previously 
described. This may provide further insight into the role of the exocyst in both 
normal and pathological conditions.  
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A multitude of cellular roles for the 
exocyst complex 
1.1 Exocytosis 
1.1.1 Functions of Exocytosis 
Exocytosis describes the process whereby secretory vesicles containing cargo 
are trafficked to the cell periphery, and fuse with the plasma membrane. 
Exocytosis is utilised for secretion and also participates in altering membrane 
composition.   
Secretion describes the transport of certain cellular macromolecules to the cell 
exterior, in order to perform a function. Examples of secreted products include 
proteins required to form the extracellular matrix, and signalling molecules.  
There are two main types of secretion: constitutive and regulated (Reviewed in 
Burgess et al., 1987). Constitutive secretion occurs when cargo need to be 
released continuously. On production, secretory vesicles are immediately 
transported to the cell surface for release. An example is the release of matrix 
metalloproteinases to break down the extracellular matrix during growth, 
organogenesis and tissue turnover (Birkedal-Hansen et al., 1993).  Regulated 
secretion occurs when the release of cargo needs to be restricted to specific 
times and/or amounts. Secretory vesicles wait inside the cell until they receive a 
signal to fuse with the membrane and release their contents. Examples of this 
include neurosecretory cells which secrete endorphins and neurotransmitters (De 
Camilli et al., 1990), and pancreatic cells which secrete insulin and glucagon 
(Burgess et al., 1987). The exocytic signal depends on the cell type; for neurons 
it is a rise in intracellular Ca2+ (Lim et al., 1990), for pancreatic β-cells it is 
increased blood glucose levels (Rutter, 2004).  
On fusion, the vesicle membrane is incorporated into the plasma membrane. In 
this way, cells also use exocytosis to both expand the plasma membrane, and 
insert proteins into it. Vesicles are constitutively secreted during normal cell 
growth to provide the lipids required to expand the plasma membrane, and they 
are incorporated into the membrane by exocytosis (Zakharenko et al., 1998). 
Any components embedded in the secretory vesicle membrane can therefore 
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be incorporated also. By this process, if cells need to alter the composition of 
the plasma membrane they can secrete vesicles containing particular lipids, 
membrane proteins and receptors, and insert them into the membrane by 
exocytosis. As a result, exocytosis is vital for processes such as cell polarity 
and cytokinesis (See Section 1.3.3).  
1.1.2 Stages of Exocytosis 
Secretory vesicles are transported to the cell periphery either passively by 
diffusion (Bendez et al., 2012), or actively by motor proteins such as kinesins, 
dyneins and myosins, which transport the vesicle along cytoskeletal filaments to 
its destination. In yeast, vesicles are typically trafficked along actin cables 
(Pruyne et al., 1998; Schott et al., 1999; Evangelista et al., 2002; Reviewed in 
Moseley et al., 2006) or by passive diffusion (Bendez et al., 2012), whilst in 
mammalian cells transport is primarily microtubule-based (Wacker et al., 1997)  
Once in the vicinity of the plasma membrane, the vesicle must then be ‘tethered’ 
and/or ‘docked’. However, the distinction between these terms is not always 
clear. One hypothesis (eg. Toonen et al., 2006) is that this step of exocytosis 
involves firstly an interaction between the vesicle and the accepting membrane 
(docking) which is promoted by mediating proteins. Other proteins then create a 
physical link (tether). Conversely, the more widely held view is that ‘tethering’ is 
in fact the initial step prior to docking, and that the difference between these steps 
is the distance between the vesicle and the plasma membrane.  
The docking stage can be defined morphologically (Hammarlund et al., 2007). 
Some authors refer to a vesicle as ‘docked’ when it is within approximately 30 nm 
of the membrane (Broadie et al., 1995; O’Connor et al., 1997). This accounts for 
the fact that fixation methods can cause changes in membrane structure, possibly 
dislodging docked vesicles.  However, this can overlook variation between 
vesicles close to the membrane, so some authors alternatively define ‘docked’ 
vesicles as those which have a visible contact patch with the membrane (Harris 
et al., 1995; Schikorski et al., 2001; Xu-Friedman et al., 2001). The presence of 
a strong association between vesicles and the plasma membrane has been 
demonstrated by two methods. Firstly, biochemical methods have shown that a 
large fraction of vesicles that appear docked remain associated with fragments 
of the plasma membrane even after homogenisation, washing and sedimentation 
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(Martin et al., 1997). This demonstrates a strong physical connection. Secondly, 
analysis of the mobility of docked vesicles using Total Internal Reflection 
Fluorescence Microscopy (TIRFM) shows that docked vesicles display very 
restricted movements compared to undocked cytoplasmic vesicles (Oheim et al., 
1998; Nofal et al., 2007), which also suggests a physical tether. As the boundary 
between tethering and docking is not well defined or understood on a molecular 
level, this often results in confusion and/or incorrect use of the terms 
interchangeably.  
Another key step during vesicle docking/tethering is the interaction between 
Soluble N-ethylmaleimide sensitive fusion Attachment Protein Receptor 
(SNARE) proteins. These are present on both the surface of the arriving vesicle, 
and in clusters on the plasma membrane (Reviewed in Lang, 2007). They were 
therefore originally named vSNAREs (for vesicle) and tSNAREs (for target 
membrane) respectively. When in close enough proximity, the SNARE proteins 
on the vesicle and plasma membrane bind to each other, forming what are known 
as trans-SNARE complexes (Söllner et al., 1993a,b). The formation of these 
complexes helps to bring the vesicle in close proximity to the plasma membrane 
for fusion to then occur. Membrane fusion is energetically costly due to the need 
to overcome the repulsive forces between the two charged lipid bilayers. 
Conformational changes in the SNARE complexes generate the force needed to 
overcome this repulsion, and bring the two membranes together (reviewed in 
Jahn et al., 2006; Gao et al., 2012). 
During regulated secretion in mammalian cells, evidence suggests that initially 
only a small percentage of docked vesicles are actually capable of responding to 
the exocytic signal and fusing with the membrane (Rosenmund et al., 1996; Xu 
et al., 1998; Klenchin et al., 2000). The majority must therefore undergo ‘priming’ 
to become fusion competent. Priming can involve several different ATP-
dependent processes including lipid synthesis, protein phosphorylation and 
rearrangement of SNARE complexes (Reviewed in Klenchin et al., 2000). 
However, the stage at which priming occurs is currently debated, and it is not 





1.2 The Exocyst Complex 
During the tethering/docking step of exocytosis, several mediating proteins are 
required to help target the secretory vesicle, secure its association with the 
membrane and ensure subsequent vesicle fusion. A heteromeric complex called 
the exocyst is one such example. It is formed of eight different protein subunits 
named Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and Exo84 in yeast, and 
Exoc1 to Exoc8 respectively in mammalian cells. 
1.2.1 Discovery 
The constituents of the exocyst were originally discovered in the budding 
yeast Saccharomyces cerevisiae. Six of the components were first found during 
a genetics screen for secretory mutants, which identified 23 gene products 
required for exocytosis (Novick et al., 1980). These proteins were named using 
the prefix ‘sec-’ for secretion, which gave rise to Sec1 - Sec23. Subsequent 
research showed that ten of these proteins are required specifically during protein 
transport from the Golgi-apparatus to the plasma membrane:  
Sec1/2/3/4/5/6/8/9/10/15 (Novick et al., 1981).   
Sec8 and Sec15 were the first to be identified as being part of a multiprotein 
complex, initially estimated to be between 1000-2000 kDa in size (Bowser et al., 
1991, 1992). It was then shown that the complex also contained Sec6 (along with 
five unidentified proteins), and was thus referred to as the ‘Sec6/8/15 complex’. 
Its molecular weight was also more accurately estimated as 743 kDa (TerBush 
et al., 1995). The same study also showed that mutation of Sec3, Sec5 or Sec10 
disrupted the integrity of the complex, thus implicating their association. They 
were subsequently proved to be members of the complex using purification and 
peptide microsequencing, and this also unearthed the seventh member of the 
complex – Exo70 (TerBush et al., 1996). It was in this study that the term ‘exocyst’ 
was first coined to describe the complex.  
Efforts to discover the mammalian components of the exocyst continued in 
parallel to those in yeast. The last member of the exocyst - Exo84  - was 
discovered during purification of the mammalian exocyst complex (Kee et al., 
1997), and its yeast counterpart was later identified by co-immunoprecipitation 
(Guo et al., 1999a).  
12 
 
1.2.2 Role in Exocytosis 
The exocyst’s classical role is thought to be in tethering secretory vesicles in 
close enough proximity to the plasma membrane to allow SNARE complexes to 
form, as outlined in Section 1.1.2, and/or in regulating SNARE complex assembly. 
However, this is a rather simplistic summary as the relationship between the 
exocyst complex and SNAREs is also not fully understood, and the tethering 
function is yet to be experimentally demonstrated. Studies in yeast have shown 
that Sec6 binds to SNARE complexes once they are assembled, which suggests 
that it promotes complex assembly, likely by a mechanism similar to other 
tethering complexes (Dubuke et al., 2015). Further evidence that the exocyst 
interacts with SNARE regulating proteins and possibly helps to localise them 
adds a further level of complexity (Carr et al., 1999; Morgera et al., 2012). It is 
therefore clear that the exocyst is involved in not just simply the tethering of 
vesicles, but also in mediating SNARE complex formation. 
The mechanism by which the exocyst complex assembles is also currently 
debated. Many studies in the past proposed that only Sec3 and Exo70 interact 
with the plasma membrane. The original model was therefore that these two 
components acted as landmarks for the rest of the complex, and thus defined the 
sites of exocytosis (Finger et al., 1998; Boyd et al., 2004; He et al., 2007; Zhang 
et al., 2008). However this model has been called into question, most notably by 
evidence that the high affinity association of the GFP construct used by Finger et 
al. with the plasma membrane was not replicated by studies of the native Sec3 
protein (Roumanie et al., 2005). This therefore suggests that the strong plasma 
membrane localisation original observed was likely an artefact of the GFP-tag. In 
addition, the observation of other exocyst components localising to the plasma 
membrane (Tsuboi et al., 2005; Songer et al., 2009) and of Sec3 and Exo70 
localising to the cytoplasm (Cubelos et al., 2005; Xu et al., 2005) further refute 
this model. So just as the structure of the assembled complex remains elusive, 






1.2.3 Biochemical & Structural Studies 
To date, the full-length crystal structures of Exo70 and Sec10, and partial 
structures of Sec3, Sec6, Sec5, Sec15, Exo84 have been resolved in various 
organisms (Fukai et al., 2003; Dong et al., 2005; Jin et al., 2005; Wu et al., 2005; 
Sivaram et al., 2006; Moore et al., 2007; Baek et al., 2010; Yamashita et al., 2010; 
Zhang et al., 2015; Chen et al., 2017). Unfortunately progress in this area remains 
slow, primarily due to the lack of soluble protein available for analysis (Croteau 
et al., 2009). Studies have shown that all of the exocyst components have related 
structures (Croteau et al., 2009) that share the same bundle topology, but each 
have unique helical packing angles, residue indels, and electrostatic and 
hydrophobic surface patterns (Sivaram et al., 2006).   
As the full-length structure of all eight components has not been solved in any 
one organism, the subunit organisation of the complete holo-complex remains 
unknown. Some studies have given an indication of how the fully-assembled 
complex may appear. One study used a quick-freeze electron microscopy (EM) 
technique to look at the mammalian exocyst complex from brain cells, and found 
that the assembled complex resembles a “T” or a “Y”  (Hsu et al., 1998, see Fig. 
9). Other studies indicated that at least four of the exocyst components have 
extended rod-like structures, and that the assembled yeast exocyst complex has 
an elongated appearance, consistent with rods being packed together (Dong et 
al., 2005; Munson et al., 2006; Heider et al., 2015). A recent study utilised live-
cell imaging and fluorescence microscopy to reconstitute the 3D structure of the 
complex in vivo, and found that the exocyst has an “open hand conformation 
made of rod-shaped subunits that are interlaced in the core” (Picco et al., 2017). 
 
1.2.4 Evolutionary Conservation 
As exocytosis is utilised by many organisms, ranging from yeast to higher plants 
(Elias et al., 2003) to metazoans (Guo et al., 1997), it is not surprising that parts 
of the exocytic machinery are also highly conserved; the exocyst complex is one 
such example (Koumandou et al., 2007). 
The individual subunits vary in their conservation across eukaryotes (See Fig. 4, 
Koumandou et al., 2007). Many Opisthokonta, as well several Amoebozoa and 
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Archaeplastida possess eight subunits, whereas studied Excavata and 
Chromalveolata only possess between one and six subunits. It has even been 
found that trypanosomes (part of the Kinetoplastida) possess a ninth exocyst 
subunit in addition to the other eight (Boehm et al., 2017). This variation in 
conservation, combined with the fact that the subunits share the same bundle 
topology (discussed in the previous section), may suggest that one exocyst 
component could perform different roles in different organisms, or even that there 
may be redundancy among components. This would also explain why not all of 
the subunits are essential in all organisms. It is thought that the different 
components evolved by multiple gene duplication and divergence events 
(Croteau et al., 2009) to enable more functions in more complex multicellular 
organisms. This perhaps explains why some organisms can function with say 
only three of the components, as they can sufficiently perform the roles of the 
complex required in that organism. Alternatively, it is possible that the other 
subunits are in fact present, but just cannot be found computationally at this 
stage.  
In yeast and metazoans, the exocyst components are typically each encoded by 
one gene. However, more complex multicellular organisms usually have a large 
number of isoforms. Taking Exo70 as the most extreme example, in S. cerevisiae 
it is encoded by one gene which produces one isoform (taken from NCBI Gene 
entry). In humans, Exo70 (Exoc7) is encoded by one gene, which is post-
transcriptionally spliced to produce seven different mRNA isoforms (taken from 
NCBI Gene entry). In plants however, exocyst subunits are often encoded by 
duplicated genes or multiple different paralogs (Cvrčková et al., 2012). In 
Arabidopsis thaliana for example, Exo70 is encoded by 23 different paralogs, and 
splicing variants have been proposed for most Arabidopsis subunits on top of this 
(Lamesch et al., 2012). This further supports that different mechanisms of 
functional specialisation, and indeed levels of redundancy, have evolved among 
different species.  
Since its discovery, research has shown that the exocyst is in fact fundamental 
to a whole host of cellular processes beyond just exocytosis. This is reflected by 
the range of phenotypes caused by its perturbation, which are apparent in both 
unicellular and multicellular organisms. In fungi for example, the majority of the 
genes encoding exocyst components are essential for viability. Exocyst mutants 
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are typically defective in polarity determination, branching, and in some cases 
plant pathogenicity or cytokinesis (reviewed in Martin-Urdiroz et al., 2016). In 
mammals, the exocyst components are similarly essential, with existing 
knockouts in mice showing early embryonic lethality (Friedrich et al., 1997; 
Mizuno et al., 2015).  
Conditional or heterogeneous knockouts display a range of developmental 
defects (reviewed in Martin-Urdiroz et al., 2016), so it is not surprising that 
mutations in human exocyst components have also been linked to disease. 
Current implicated diseases/syndromes include ciliopathies (See Section 1.1.8), 
cancers (Camonis et al., 2005; Armaghany et al., 2012), intellectual development 
and electrophysical stability (Fruhmesser et al., 2013), as well as facial defects 


















1.3 Cellular Roles of Sec8 
Despite being one of the earliest members of the exocyst to be identified, Sec8 
is the only component currently with no crystal structure characterisation (see 
Section 1.2.3). Nonetheless, studies have demonstrated its involvement in a host 
of cellular processes, including several beyond the exocyst’s canonical role in 
vesicle trafficking and tethering. These are summarised in Figure 1, and 
discussed below. The molecular mechanism of Sec8’s involvement is not well 
understood in many of these cases. In addition, most of these studies only 
examine a limited number of exocyst components, meaning that whilst they 
demonstrate novel roles, these cannot be assigned as specific to Sec8 itself. It is 
highly likely that the rest of the complex participates in these functions, and that 
the whole complex is disrupted by perturbation of Sec8. However, for the 
purposes of this thesis, I will summarise the literature specifically pertaining to 
Sec8.   
1.3.1 Discovery and Conservation 
As discussed in Section 1.2.1, Sec8 was originally discovered in a screen for 
secretion mutants in S. cerevisiae (Novick et al., 1980), and it was one of the 
earliest to be identified as a member of the exocyst complex (Bowser et al., 1992). 
Mammalian Sec8 (Exoc4) was first identified in the rat brain (Ting et al., 1995). It 
was part of a soluble 17S particle, thought to assist in the regulation of vesicle 
docking and fusion in the brain. This particle showed homology to the putative 
exocyst complex that had been described in yeast at the time, and was 
subsequently named the ‘sec6/8 complex’ (Hsu et al., 1996). This complex 
localised to the plasma membrane in nerve terminals, and co-immunoprecipitated 
with the tSNARE syntaxin. These results gave the first implications that the 
mammalian exocyst complex had a role in vesicle docking and fusion. Since its 
initial discovery, studies have demonstrated its role in multiple cellular processes, 
even before the discovery of the other exocyst components.  
Sec8 is highly conserved among eukaryotes; homologs or orthologs can be 
found from unicellular yeast to humans. The NCBI entry for human sec8 lists 
193 bilaterian organisms alone with an ortholog. Table 1 lists examples from 











Figure 1: Sec8 has described roles in a wide variety of cellular processes, including many beyond exocytosis
The leftmost panels represent cellular processes in which Sec8 has shown to be involved in secretion; (A) Neuronal secretion and myelination (B) 
Insulin secretion (C) Matrix degradation. Either directly or indirectly through its role in exocytosis, Sec8 can also influence (D) Cytokinesis and (E) 
Polarity. The rightmost panels represent emerging non-canonical roles of Sec8, where it is thought to either regulate protein expression or protein 
localisation, or coordinate protein/enzymatic interactions: (F) Autophagy (G) Apoptotic Signalling (H) Cell cycle control (I) DNA Repair (J) Ciliogenesis 










Table 1: Sec8 homologues and orthologues retrieved by the NCBI HomoloGene 


















exoc4 M. mulatta XP_001101640.2 98.8 
exoc4 C. lupus XP_539369. 97.0 
exoc4 B. taurus NP_001095677.1 96.4 





exoc4 G. gallus NP_001186249.1 89.9 
exoc4 X. tropicalis NP_001025305.1 87.3 
















sec8 S. cerevisiae NP_015380.1 - 
klla0e11419g K. lactis XP_454464.1 38.0 
agos_adl317c E. gossypii NP_983779.2 40.3 
sec8 S. pombe NP_587846.2 22.5 
mgg_03985 M. oryzae XP_003719868.1 25.1 














 sec8 A. thaliana NP_566372.1           - 
os08g0318500 O. sativa NP_001061521.1 63.7 
 
a ‘core’ exocyst component, as it is one of the six members with a wide taxon 
distribution (Koumandou et al., 2007).  
Since the exocyst’s canonical role in vesicle tethering during the late secretory 
pathway was described, studies have gone on to demonstrate that Sec8 is 
required to perform this function during both regulated and constitutive 
                                                          
1 Protein identities were calculated by the HomoloGene system using blastp. Each protein is compared 
against the first gene/organism in its taxonomic group (highlighted in bold). 
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secretion, in a wide range of cellular contexts. Some examples of this will be 
discussed below. 
1.3.2 Sec8 is Directly Involved in the Secretion of Multiple Proteins 
Neuronal Secretion  
Due to its discovery in the brain, much of the original research into Sec8’s function 
in mammalian cells was conducted in neurons. It has been shown to be required 
for multiple types of secretion in neuronal cells. 
The exocyst complex localises at regions of neuronal growth (Hazuka et al., 
1999) and is involved in both vesicle targeting (Vega et al., 2001) and membrane 
trafficking (Teodoro et al., 2013) at synapses. It has also been shown to assist 
RalA - a GTPase and upstream regulator of the exocyst (Moskalenko et al., 2002) 
– in the modulation of synaptic strength by influencing the pool of primed synaptic 
vesicles (Polzin et al., 2002). Sec8 was shown to directly interact with the effector 
domain of active RalA, and when this interaction is inhibited, neurosecretion is 
suppressed. However, the consensus from more recent studies seems to be that 
the exocyst is involved in the proper function of synapses, but not directly in 
neurotransmitter release (Murthy et al., 2003) .  
Trafficking by the exocyst has also been shown to help localise proteins at 
synapses that are required for ‘synaptic plasticity’ - this describes the ability of 
neurons to alter their response to a certain stimulus over time, which is required 
for processes such as learning to occur in higher organisms. PSD-95 is a synaptic 
scaffolding protein of the MAGUK family, which plays a key role in correctly 
localising proteins at excitatory synapses, and subsequently synaptic plasticity. 
PSD-95 has been shown to physically interact with Sec8 (Riefler et al., 2003), 
and CyPIN - a PSD-95 interactor, thought to regulate dendrite morphology (Akum 
et al., 2004) - can competitively disrupt this interaction with Sec8. As to the 
importance of this interaction, the authors speculate that as PSD-95 associates 
with vesicles and microtubules as it localises to the synapse (El-Husseini et al., 
2000), it likely associates with Sec8 during this trafficking, and CyPIN prevents 
targeting to the synapse by blocking this interaction. However, it is still not 
understood exactly how the exocyst helps to traffic/target PSD-95. Perhaps Sec8 
is on the surface of vesicles travelling to the synapse, and binds to PSD-95 thus 
transporting it.   
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The exocyst is also involved in the trafficking of receptors. Ionotropic glutamate 
receptors (GluRs) are a class of receptors that localise to excitatory synapses 
and play a key role in regulating excitatory neurotransmission (Dingledine et al., 
1999). NMDAR is one such receptor. SAP102 is the major MAGUK protein 
expressed in neurons (Sans et al., 2000; Standley et al., 2000), and is speculated 
to interact with NMDARs during transport and function (Sans et al., 2003). Sec8 
was shown to physically interact with Sap102, and together they complex with 
NMDARs in the ER (Sans et al., 2003). In addition, this Sec8-Sap102 complex is 
required for NMDAR to be delivered to the cell surface in neurons. Sec8 has also 
been shown to assist in both the delivery of AMPAR, another GluR, to the 
synapse (Gerges et al., 2006). Together this demonstrates an essential role for 
the exocyst in delivering receptors to the excitatory synapse. Again, it is not fully 
elucidated how the exocyst performs this transport, but the physical interaction 
indicates it plays a direct role.  
Sec8 has also been implicated in myelination, a process whereby 
oligodendrocytes secrete layers of myelin that surround neuronal axons, thus 
creating an insulating layer (Pfeiffer et al., 1993; Barres et al., 1999). Myelination 
serves to protect the axon, facilitate signalling between oligodendrocytes and 
neurons, and increase the efficiency of signal transduction. Sec8 physically 
interacts with OSP and CASK, two proteins that are shown to be essential for 
myelin synthesis (Anitei et al., 2006). Sec8 clearly plays a central role, as its 
inhibition reduces myelin production and its overexpression promotes myelin-like 
membrane formation. It is thought that Sec8 forms a complex with OSP and 
CASK that regulates the transport of myelin proteins to sites of membrane growth 
by influencing vesicle recruitment, but the exact mechanism of Sec8’s 
involvement remains to be confirmed. Sec8 has also been implicated in the 
regulation of membrane homeostasis in myelination through an interaction with 
Dlg1 – a scaffold protein involved in polarised vesicle trafficking and membrane 
addition (Lee et al., 2003; Gorczyca et al., 2007). It is thought that Dlg1 regulates 
the balance between Sec8-mediated membrane addition and Mtmr2-mediated 
membrane remodelling (Bolis et al., 2009). This is an example of Sec8’s role in 




As mentioned in Section 1.1.1, secretion of insulin by pancreatic β-cells is a prime 
example of regulated secretion. Large insulin-containing vesicles remain in the 
cytoplasm until a rise in external blood glucose concentration causes changes in 
intracellular ATP and Ca2+ concentrations, which in turn stimulates exocytosis (for 
details see Rutter, 2004). There are thought to be ‘reserve’, ‘intermediate’ and 
‘primed/docked’ pools of vesicles, which are both morphologically and 
biochemically distinct (Rorsman, 1997; also discussed in Section 1.1.7; 
Bratanova-Tochkova et al., 2002). This results in a bi-phasic release of insulin – 
the primed pre-docked vesicles are exocytosed immediately upon stimulation, 
thus forming the first phase, and the reserve/intermediate pools are recruited and 
then exocytosed, this delay forming the second phase (Barg et al., 2002). The 
exocyst complex is required to dock insulin vesicles at the plasma membrane 
prior to exocytosis. Perturbation of Sec8 inhibits this process (Tsuboi et al., 2005; 
Xie et al., 2013), and thus it has been speculated that exocyst defects could 
potentially have links to diabetes. Sec8 has also been shown to directly bind to 
MyRIP, a synaptotagmin-like protein that functions as a PKA-anchoring protein. 
Sec8 and MyRIP co-localise in the perinuclear region in INS-1 cells (Goehring et 
al., 2007). It is therefore suggested that together, a complex of MyRIP, the 
exocyst and the PKA holoenzyme regulate the mobilisation and membrane 
recruitment of insulin vesicles.  
In addition, Sec8 has been shown to localise at the plasma membrane of MIN6 
β-cells, whereas Sec6 and Sec10 were shown to localise on the vesicles and in 
the cytoplasm respectively (Tsuboi et al., 2005). This is contrary to the proposed 
model discussed in Section 1.2.2 where Sec3 and Exo70 are the exocyst 
components that associate with the plasma membrane. It is therefore suggested 
that Sec8 may be recruited to the membrane (along with other exocyst members), 
and Sec6 is delivered on the arriving insulin vesicles.  
Extracellular Matrix Degradation 
During the maturation of cancer tumours, malignant cells can often spread to 
other parts of the body in a process known as metastasis. These invasive cells 
can escape the tissue surrounding the primary tumour, penetrate the walls of the 
blood vessels and travel to a new site, where they invade secondary tissues 
(Reviewed in Ha et al., 2013; Alizadeh et al., 2014). Invasive cells must be able 
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to degrade the extracellular matrix of tissues and epithelial layers during this 
process in order to migrate through the three-dimensional environment (Mignatti 
et al., 1993; Stetler-Stevenson et al., 1993; Ray et al., 1994; Reviewed in Brown 
et al., 2015). They therefore form specialised actin-rich membrane protrusions 
called invadopodia,  which help to degrade the extracellular matrix, amongst other 
functions (Weaver, 2006; Murphy et al., 2011).   
Sec8 has been shown to be required for the secretion of matrix-degrading 
enzymes from invadopodia. Upon reduction or mutation of Sec8, matrix 
degradation is drastically inhibited (Sakurai-Yageta et al., 2008), and the 
secretion of multiple different matrix-degrading enzymes is reduced (Yamamoto 
et al., 2013). This indicates that the exocyst likely plays an essential role in the 
targeting and trafficking of these enzymes during invasion. In addition, Sec8 
interacts with IQGAP1 (Sakurai-Yageta et al., 2008), a master polarity protein 
whose expression promotes matrix degradation (Nabeshima et al., 2002; 
Mataraza et al., 2003; Sakurai-Yageta et al., 2008). When IQGAP1 cannot bind 
to the exocyst, this enhancement of matrix degradation is lost, suggesting that 
Sec8 may also be involved in more complex regulation of invadopodial 
processes.  
1.3.3 Through Its Role in Exocytosis, Sec8 Controls Cell Division 
and Polarity 
The exocyst’s role in targeting membrane and vesicle trafficking has also been 
shown to function in other processes where cellular traffic needs to be directed 
to specific sites. Examples include both cell division, and the induction and 
maintenance of polarity. Establishing polarity is essential for the functions of cells 
in a variety of contexts, on both the cellular and tissue level. Examples range from 
governing the location of cells in the developing embryo, to the formation of neural 
networks and the organisation of epithelial cell layers. Sec8 has been shown to 
participate in polarity induction and maintenance in multiple cell types. 
Cytokinesis 
There are several lines of evidence which demonstrate that the exocyst is 
involved in cytokinesis – the culminating step of the cell cycle which sees the 
cytoplasm physically divided, and the two daughter cells fully separated. Exocyst 
components interact with several trafficking proteins that are required for 
23 
 
cytokinesis, including Rab11 (Zhang et al., 2004; Neto et al., 2013), Arf6 (Prigent 
et al., 2003) and the Ral GTPases (Chen et al., 2006. Other examples discussed 
throughout Section 1.3).  
Sec8 shows a high degree of colocalisation with Rab11 (Rivera-Molina et al., 
2013), and depletion of Rab11 results in a decrease in Sec8 levels. During 
mitosis, mammalian Sec8 associates with the mitotic spindle and spindle poles, 
and during cytokinesis it associates with the central spindle and the midbody 
(Chen et al., 2006). When at the midbody, Sec8 is anchored within a ring-like 
structure by centriolin (Gromley et al., 2005). Mutation of Sec8 results in delayed 
abscission, and an increased proportion of binucleate cells (Gromley et al., 2005; 
Neto et al., 2013), indicating it is required for the final stages of cytokinesis. Prior 
to abscission, secretory vesicles are delivered asymmetrically to the midbody 
(Gromley et al., 2005). It is likely that Sec8 is required for the targeting and/or 
docking of these vesicles.  
Examination of Sec8 in fission yeast supports this deduction. Cytokinesis in such 
yeast has an additional step in that the division septum (formed of cell wall 
components) must be broken down. Sec8 localises to the growing tips, and in 
rings on either side of the contractile ring at the division site (Wang et al., 2002). 
Mutation of Sec8 causes severe extracellular septation defects, and ‘presumptive 
secretory vesicles’ accumulate at either side of the formed septum, which 
indicates a tethering/docking defect. This is thought to block the secretion of 
enzymes that degrade the primary septum during cytokinesis, but has not yet 
been demonstrated. So Sec8 is required for the late stages of cytokinesis, and 
its role is likely in the tethering and/or docking of secretory vesicles. 
Neuronal Polarity 
Neurons are a highly specialised cell type. In order to properly transmit signals, 
maturing neurons must break symmetry and establish polarisation. This enables 
the formation two cellular compartments – axons and dendrites – which are 
functionally and structurally distinct (Arimura et al., 2007; Barnes et al., 2008). 
The relocation of the PAR/aPKC complex to the developing axon is a key step 
during neuron polarisation (Y. M. Chen et al., 2006; Arimura et al., 2007). Sec8 
physically interacts with both Par-3 (a member of the PAR complex) and aPKC 
in polarising neurons (Lalli, 2009). The exocyst is a known effector of the Ral 
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GTPases RalA and RalB (Moskalenko et al., 2002). In the absence of either RalA 
or Sec8, neurons fail to polarise and Par-3 does not relocate to the developing 
tip (Lalli, 2009). Together, this demonstrates a RalA-regulated association 
between the exocyst and the PAR/aPKC complex, which is essential for the 
latter’s relocation during neuron polarisation. The mechanism by which the Sec8 
participates in trafficking the complex remains to be confirmed, but this is clearly 
required to establish neuronal polarity. 
Epithelial Polarity 
Sec8 also has a described role in polarity induction and maintenance in epithelial 
cells. When epithelial cells (such as MDCK cells, from kidney tissue) form a 
monolayer, they adhere to their substrate, adhere to their neighbours, and form 
cell-cell junctions. This in turn induces apical-basal polarity. In mammalian 
epithelia, the apical and basolateral regions are separated by tight junctions 
(TJs), protein complexes which join adjacent cell membranes to form an 
impermeable barrier and seal the monolayer. An important requirement when 
establishing polarity is the asymmetric trafficking of vesicles. Basolateral traffic is 
delivered to the plasma membrane region adjacent to TJs. The exocyst is known 
to be involved in this process. Par-3, the polarity protein discussed previously in 
the context of neuronal polarity, is the receptor which targets the exocyst to these 
sites (Ahmed et al., 2017). 
Sec8 is required for trafficking vesicles specifically to the basolateral membrane 
of MDCK cells (Grindstaff et al., 1998; Lipschutz et al., 2000). In its absence, 
proteins which are destined for the basolateral membrane are not delivered. Sec8 
has also been shown to localise closely with the TJ protein occludin (Charron et 
al., 2000), indicating an interaction at TJs also.   
1.3.4 Emerging Non-conventional Roles of Sec8 
Beyond roles in vesicle transport and tethering, the exocyst has been shown to 
be involved in several key signalling pathways. The only known structural motifs 
identified within Sec8 are a ‘sec8 specific domain’ of unknown function, and a 
PDZ-binding domain identified in the rat sequence (Sans et al., 2003). PDZ 
domains are commonly found in cellular signalling proteins (Reviewed in Jeleń et 
al., 2003; Lee et al., 2010), and recognise specific sequences in order to help 
assemble protein complexes. As Sec8 has a binding region for this domain, this 
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supports that Sec8 likely interacts with proteins in signalling pathways. An 
increasing amount of literature seems to suggest that Sec8 can regulate protein 
expression, and that it may function as a physical platform to coordinate protein 
and enzymatic interactions. The evidence for such roles, described in different 
cellular contexts, will be discussed in this section.  
Macroautophagy 
Macroautophagy is the process by which cytoplasmic components are targeted 
for degradation. They are packaged in a double-membrane vesicle called an 
autophagosome, which then fuses with the lysosome, allowing breakdown of the 
contents by the lysosomal acid hydrolases (For Reviews, see Wong et al., 2011; 
Feng et al., 2014). The exocyst has been shown to act as a platform for the 
assembly and activation of different components of the autophagy machinery in 
mammalian cells; RalB, a regulator of the exocyst, acts a regulatory switch for 
autophagosome biogenesis. When activated, RalB binds to Exo84 and induces 
complexes of catalytically active autophagy proteins to assemble on the exocyst. 
When RalB is inactive, a suppressed complex of these proteins instead 
associates with Sec5 (Bodemann et al., 2011; Farré et al., 2011). 
Whilst depletion of Sec8 suppresses autophagy (Farré et al., 2011) indicating it 
too is essential, it would seem that its role is separate from that described above 
for Exo84/Sec5. Sec8 associates with a complex of Atg12 and Atg5, which is part 
of the autophagy machinery that specifically is involved in elongation of the 
isolation membrane. The exact nature of Sec8’s contribution is yet to be 
determined. It is possible that Sec8 may be part of the Sec5 or Exo84 
subcomplexes, but was not identified in the study. Perhaps its loss affects the 
stability and/or localisation of these complexes, or alternatively it may affect the 
localisation and/or function of Atg12/Atg5 by a mechanism which is not currently 
characterised.  
Apoptosis 
Apoptosis, or programmed cell death, is the process by which redundant or 
damaged cells are destroyed. Its induction and maintenance is tightly controlled 
by multiple signalling pathways (Reviewed in Ashkenazi et al., 2014).  JNK is a 
component of the mammalian MAPK signalling pathway (Johnson et al., 2002), 
which when phosphorylated can trigger expression of proapoptotic proteins (Dent 
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et al., 2003). JIP4 is a JNK-interacting scaffolding protein and has been 
implicated in the p38 MAPK pathway (Kelkar et al., 2005), which can also induce 
apoptosis under certain conditions (Zarubin et al., 2005; Hasegawa et al., 2012). 
JIP4 has been shown to physically interact with Sec8, but not Sec6 (Tanaka et 
al., 2014). Furthermore, depletion of Sec8 resulted in suppression of apoptosis 
and increased viability of cells, by supressing the phosphorylation of JNK and 
p38. This suppression is caused by increased binding to and subsequently 
reduced activation of MKK4, a protein kinase kinase which phosphorylates JNK 
and p38 when activated (Kelkar et al., 2005; Wang et al., 2007).  
Together this demonstrates an important role for Sec8 in both modifying protein 
expression, and in regulating the MAPK signalling pathway and subsequently 
apoptosis. However, the molecular mechanism by which it causes increased 
binding of JIP4 to MKK4 is not known. The authors speculate that Sec8 may 
function as a local adaptor protein, and may sequester JIP4 and its associated 
kinases to specific areas upon pathway activation, thus promoting their activation. 
This provides initial evidence that Sec8 can act to somehow regulate protein 
interactions.   
Cell Cycle Control 
Progression through the cell-cycle is controlled by cyclin-dependent kinases 
(CDKs), whose activity is in turn regulated positively by cyclin binding and 
negatively by CDK inhibitors (CKIs). When a cell reaches the G1/S phase 
boundary, a checkpoint ensures that the DNA replication does not proceed if the 
DNA is damaged (Figure 2). Briefly, when a cell normally reaches this checkpoint 
at the end of G1 phase, p21Cip1 inhibits the activity of cyclins, and the Cdk2/cyclin 
E complex ensures complete phosphorylation of retinoblastoma protein (Rb). 
This then then releases E2F factor, which enables expression of S-phase genes. 
However if DNA damage has occurred, p21Cip1 instead inhibits the activity of 
Cdk2, which results in hypophosphorylated Rb, which then binds the E2F factor, 
preventing expression of S-phase genes and causing the cell cycle to arrest 
(Cazzalini et al., 2010; Hydbring et al., 2010). This cell cycle arrest at the G1/S 
boundary can also be promoted by the expression of FOXO transcription factors 







It has been shown that Sec8 can regulate FOXO transcription factors, and in turn 
affect p21 and cell-cycle progression (Tanaka et al., 2014a). This study showed 
that knockdown of Sec8 in human cell lines resulted in reduced mRNA levels of 
Mdm2, an E3 ligase which targets FOXO factors for degradation by promoting 
their ubiquitination (Brenkman et al., 2008; Fu et al., 2009). This influenced the 
polyubiquitination of FOXO factors, and resulted in the increase of either FOXO1 
or FOXO4 mRNA levels (depending on the cell type). This in turn resulted in 
increased levels of p21 mRNA, which causes reduced cell proliferation, reduced 
phosphorylated Rb and ultimately cell-cycle arrest. This demonstrates an 
important role for Sec8 in regulating cell-cycle arrest, but the mechanism by which 
it controls Mdm2 expression is not known. The authors speculate that Sec8 may 
be involved in nuclear export of mRNA or may influence other related signalling 
pathways, but this would be quite a contrast to the exocyst’s currently described 
cellular functions.  
DNA Repair 
Several different types of DNA damage can stimulate the p53 tumour suppressor 
network (Lakin et al., 1999), which as its name suggests acts to suppress 
tumorigenesis and promote genomic stability, amongst other roles. p53 is a 
transcription factor, which is phosphorylated in response to stress such as DNA 
damage. This activation results in an increase in both the levels and the DNA-
binding affinity of p53 (Reviewed in Lakin et al., 1999). Depending on the severity 
of the damage, this results in the expression of genes promoting either apoptosis, 
cell-cycle arrest, DNA repair or differentiation (Hupp et al., 1992; el-Deiry, 1998).  
Figure 2: 
Regulation of p21 
activity at the 
G1/S Checkpoint. 
Based on 
Cazzalini et al., 
2010 and 
Hydbring et al., 




Sec8 has been shown to play a role in modulating the DNA damage response. 
Depletion of Sec8 results in increased genomic instability, and also promotes the 
expression of p53 network downstream target genes (Torres et al., 2015). 
Furthermore, it was shown that Sec8 assists in the repair of double-stranded 
breaks (DSBs), as its depletion not only sensitised cells to the formation/detection 
of DSBs, but also reduced the persistence of the ensuing repair response. Sec8 
may play a role in repair pathway choice  (Torres et al., 2015). It directly interacts 
with 53BP1, an adaptor protein involved in repair pathway choice, and this 
interaction is disrupted upon induction of DNA damage. Depletion of Sec8 
increased the resolution of DSBs by homologous recombination (HR) as opposed 
to non-homologous end joining (NHEJ), and altered the levels of histone-
modifying proteins AFT2 and RNF20 which promote either the HR or NHEJ repair 
pathways. The authors therefore suggest that the exocyst complex acts a 
“spatially constrained platform from which to effectively coordinate localized 
enzyme/substrate interactions”, and that in this context it limits the activity of 
chromatin remodelling proteins until DNA damage actually occurs. In the absence 
of Sec8, the DNA repair that occurs has a high level of recombination but low 
fidelity, which ultimately results in chromosomal aberrations and genomic 
instability.  
Given what is already demonstrated about the cellular functions of the exocyst 
complex, an intranuclear involvement in DNA repair seems very unlikely, and it 
is hard to fathom a mechanism for such a role. Yet, it would seem that the 
evidence for Sec8’s roles in both DNA repair and cell-cycle regulation (Section 
1.3.4) are closely linked. Sec8 appears to alter the expression of Mdm2, as 
previously discussed in relation to cell-cycle progression. However, Mdm2 can 
also inhibit p53, both by competitively binding to its N-terminus thus blocking its 
interaction with the transcriptional machinery, and by modulating the stability of 
the p53 protein (both reviewed in Lakin et al., 1999; Alarcon-Vargas, 2002). Also, 
p53 has been shown to stimulate increased transcription of p21 (Reviewed in Ko 
et al., 1996; Levine, 1997), which inhibits cell-cycle progression as previously 
discussed. It is therefore possible that these two roles are connected. Further 





As discussed in Section 1.1.1, Sec8 is involved in the secretion of matrix-
degrading enzymes from invadopodia during cancer cell invasion. However, 
knockdown of Sec8 was also shown to suppress cell migration in a metastatic 
cell line (Tanaka et al., 2015).  Cytokeratin8 is an epithelial-specific intermediate 
filament, which has been implicated in cell migration and tumour metastasis 
(Bordeleau et al., 2010; Pan et al., 2013). Two MAPK signalling proteins – ERK 
and p38 – which are known to be essential for cell migration (Reviwed in Huang 
et al., 2004), can induce the phosphorylation and reorganisation of cytokeratin8, 
thus promoting cell migration (Ku et al., 2002). Knockdown of Sec8 affects the 
expression of two upstream regulators - Pirh2 and Siah1 - which ultimately 
culminates in reduced phosphorylation of ERK and p38, subsequently reduced 
phosphorylation of cytokeratin8, and suppression of cell migration. Thus Sec8 
can regulate the expression levels of proteins which are required to promote cell 
migration. However the physical mechanism by which this regulation is achieved 
this remains unclear.   
1.3.5 The Exocyst can Perform Multiple Different Roles in Order to 
Orchestrate a Cellular Function  
A further example of the exocyst’s broad and far reaching roles can be found in 
ciliogenesis, where it performs multiple different roles in order contribute to an 
overall function: the formation and maintenance of a vital organelle.  
Cilia are eukaryotic organelles, consisting of a microtubule-based axoneme that 
projects from the cell surface and is encased by the plasma membrane. Found in 
virtually every cell type throughout the mammalian body, cilia can have both 
motile functions (Reviewed in: Ibañez-Tallon et al., 2003) and immotile signalling 
roles (Reviewed in: Berbari et al., 2009; Goetz et al., 2010).The base of the cilium 
becomes a focal point for vesicular and membrane trafficking, and several groups 
of proteins are required to achieve this. Three Rab GTPases – Rab8, Rab10 and 
Rab11 - have well-described roles in this process, particularly with regard to 
membrane and vesicle trafficking (Babbey et al., 2010; Reviewed in Das et al., 
2011). They execute these roles by influencing their downstream effectors, one 
of which is the exocyst. Several exocyst members have been shown to localise 
at the base of cilia in MDCK cells (Rogers et al., 2004; Park et al., 2008), and 
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interact with the Rab proteins (Guo et al., 1999b; Zhang et al., 2004; Wu et al., 
2005).  
Sec8 has been shown to co-localise with Rab10 and Sec6 in apical rings prior to 
ciliogenesis, and at the ciliary base once formed (Babbey et al., 2010). Sec8 also 
physically interacts and complexes with Rab10. The study suggests that the 
exocyst and Rab10 may be involved in mediating membrane transport to the 
primary cilium. Examination of the exocyst in photoreceptor rod outer segments 
(a specialised ciliary-derived structure) showed that, at the base of the 
photoreceptor-connecting cilium, Sec8 co-localised with Rab8 at sites of vesicle 
fusion (Mazelova et al., 2009). This suggests that in addition to membrane 
transport, the exocyst may perform a tethering role at the base of cilia similar to 
its one in polarised exocytosis.  
One study has also implicated the exocyst in the formation of cilia, specifically in 
the migration and docking of the centrosome during ciliogenesis (Park et al., 
2008). During ciliogenesis, the centrosome/basal body migrates to the cell 
periphery. It is used to nucleate a ciliary axoneme either directly at the plasma 
membrane, or within an intracellular ciliary vesicle which subsequently fuses with 
the plasma membrane (Sorokin, 1968). Dishevelled – a protein member of the 
planar cell polarity (PCP) signalling pathway - was shown to be essential for both 
the apical positioning of the basal bodies and their association with ciliary vesicles 
(Park et al., 2008). Interestingly, whilst in wildtype multi-ciliated cells Sec8 
localises in puncta that associate with basal bodies, knockdown of Dishevelled 
causes this association to be lost. A disorganised cytoplasmic localisation was 
instead observed, with Sec8-positive structures often localising at the apical 
membrane in the absence of any docked basal bodies. This suggests that Sec8 
is in fact a component of the ciliary vesicle, which requires Dishevelled in order 
to associate with a basal body, but can still dock at the apical membrane in the 
absence of one. This poses a role for Sec8 in not only trafficking to the base of 
formed cilia, but also in the regulation of the apical membrane docking of basal 
bodies during ciliogenesis.  
Dysgenesis or dysfunction of cilia causes a severe class of syndromes 
collectively known as ciliopathies (Reviewed in: Badano et al., 2006; Waters et 
al., 2011). To the author’s knowledge, there is only currently one described case 
31 
 
of a human patient with a mutation in a coding region of Sec8, and they displayed 
symptoms aligning with the severe lethal ciliopathy MKS (Shaheen et al., 2013). 
The fact that mutation of exocyst components can cause ciliary-related disease 
highlights that their role in ciliogenesis and maintenance must be an essential 























1.4 Perspectives and Outstanding Questions 
1.4.1 The Possibility of Sub-complexes 
Currently, a controversial issue regarding the exocyst complex is the possible 
existence of sub-complexes. It is widely debated as to whether the complex 
assembles and functions as a whole, or if subcomplexes of exocyst components 
actually perform unique and separate functions within the cell. Recent evidence 
(Heider et al., 2015) indicates that the yeast exocyst is present as a complete 
complex. However, subcomplexes appear to be present in mammalian cells 
(Moskalenko et al., 2003; Bodemann et al., 2011). I will discuss the evidence for 
the existence of subcomplexes below. 
Several studies have observed, by immunofluorescence, that different exocyst 
components also have different subcellular locations. However, a recent paper 
raised important questions about the effect of both antibody epitopes and exocyst 
conformation on subcellular localisation. Inamdaret al. (2016) used antibodies 
that recognised 20 different epitopes in six regions of mSec6, with the theory that 
conformational changes in the exocyst may cover/uncover different binding sites. 
They found that the different antibodies showed different subcellular localisations. 
Firstly, this demonstrates that exocyst exists in different conformations in different 
areas of the cell, likely to perform its different cellular roles. It also suggests that 
the results and subsequent deductions made from immunofluorescence and 
immunoprecipitation studies could have been unknowingly influenced by the 
choice of antibody. These are important considerations going forward, as 
perhaps different subcellular localisations of exocyst components would indicate 
not subcomplexes, but the detection of different conformations of the fully 
assembled complex. It also raises the possibility that localisations, interactions 
and roles of Sec8 have not yet been discovered, as available antibodies may not 
detect it in certain conformations of the exocyst complex.   
Studies using methods other than immunofluorescence have also shown that 
subsets of exocyst components exist separately prior to assembly (Shin et al., 
2000; Moskalenko et al., 2003; Boyd et al., 2004). However, this only 
demonstrates that such sub-complexes exist in different subcellular locations. As 
to whether these sub-complexes have independent and/or unique functions prior 
to the assembly of the whole complex, the field is yet to be convinced. Some 
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studies have demonstrated distinct roles for individual exocyst components, such 
as Gerges et al. (2006) who when examining the delivery of AMPAR to excitatory 
synapses found that whilst Sec8 was required for the directional transport of 
AMPAR towards the synapse, Exo70 was required for insertion of the receptors 
into the membrane. This was supported by multiple observations. This poses the 
question as to whether these proteins are in fact functioning independently, or 
whether they are complexed with other members of the exocyst when performing 
these functions. When elucidating the molecular mechanisms of Sec8’s 
involvement in cellular processes, it will be important to determine whether it is 
part of the complete complex when it is performing these roles, as this would 
perhaps influence protein folding and binding ability.   
There is also a possible argument for the existence of subcomplexes from an 
evolutionary perspective. As discussed in Section 1.2.4, the exocyst components 
share structural similarities that indicate they likely evolved from multiple gene 
duplication and divergence events, and can therefore possibly perform each 
others roles in some contexts. Many eukaryotes only possess between one and 
six of the exocyst components, which either suggests that the other components 
cannot be detected computationally, or that these ‘sub-complexes’ can actually 
function sufficiently. This could give evidence to the idea that sub-complexes of 
the components in mammalian cells could in fact perform some specific or less 
specialised functions. Additionally, in the eukaryotic protist Trypanosoma brucei, 
there are in fact nine exocyst components (Boehm et al., 2017) - could this mean 
that even the mammalian exocyst is actually a ‘subset’ of components? 
Knowing how the complete complex fits together would be a helpful contribution 
to the discussion on this issue, but this cannot be known for sure until the full 
structure of each of the subunits is resolved (See 1.2.4). Only then can we begin 
exploring the possibility of different interactions between subunits, and how these 







1.4.2 Elucidating the Roles of Exocyst Components 
One question raised by the research into the exocyst’s cellular roles is the issue 
of assigning function to specific exocyst components, versus the exocyst complex 
as a whole, especially given the speculation surrounding subcomplexes. As the 
importance of the exocyst complex was recognised relatively early on, research 
into its cellular functions in different organisms exploded, often before 
homologues of all the components had actually been identified. As a result, many 
papers only examined exocyst components which had been identified at the time. 
More recent studies have the same issue, but that is now likely due to the 
availability of antibodies and the fact that it is not time or cost-efficient to replicate 
experiments with the eight different components.  
Many studies therefore often use between one and three individual exocyst 
components as a ‘markers’ for the whole complex. They then test their 
hypotheses using the marker(s), and suggest that any results extend to the rest 
of the complex. Just to select one example, Hazukaet al. (1999) use Sec6 and 
Sec8 as markers for immunofluorescent localisation of the whole exocyst 
complex because they are “stable components”. However, it could be possible 
that a subcomplex including Sec6 and Sec8 displays this localisation, and that 
other components of the exocyst could be localised elsewhere.  
On the other hand, some studies that only test (or report that they only test) a 
marker of the complex can therefore rightly only attribute the results to that one 
component. For example, Park et al.(2009) state that because they speculated a 
role for the exocyst in the interaction between the protein ‘Dvl’ and basal bodies 
during ciliogenesis, they immunostained for Sec8 to test their hypothesis. The 
study goes on to demonstrate a role for Sec8 in basal body docking. However, it 
is entirely possible that the rest of the exocyst is involved in this interaction, and 
that this not an exclusive role of Sec8 – we just do not know. The other 
components of the exocyst have demonstrated roles in an even wider range of 
cellular process, including endocytosis, cell adhesion, nanotube formation, 
calcium signalling, tubulin polymerisation, pre-mRNA splicing and lipid interaction 
to name but a few (Reviewed in Tanaka et al., 2017). It is possible that Sec8 




1.4.3 Undiscovered Functions 
With the exocyst being implicated in so many different and far-ranging cellular 
processes, it is almost easier to ask what it is not involved in. However this 
ubiquity can make it difficult to tease apart specific interaction pathways and 
determine the direct mechanism by which the exocyst is contributing to these 
processes. One of the main issues limiting more detailed functional analysis of 
Sec8’s roles is the fact that deletion of Sec8 is embryonically lethal in higher 
organisms. Together, this results in many publications about Sec8 reporting 
phenotypes but no molecular mechanism.  
It also begs the question – what other roles have we not discovered yet? The 
exocyst is hypothesised to likely be involved in many diseases, including 
ciliopathies, retinal degeneration, diabetes, cancers, obesity, kidney disease, 
neural degeneration and many more. But as it is still not fully understood how the 
exocyst functions in these cellular processes at the molecular level, it is only 
speculation at this point. The emergence of several human patients with exocyst 
mutations underlying serious disease however (see Section 1.2.4), demonstrates 
the urgent need to rectify this.  
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1.5 Aims of This Study 
This project aimed to a) better characterise the known cellular roles of Sec8 and 
b) potentially discover new cellular roles, through two key research avenues: 
firstly, through identification of its interaction partners by combining a GFP-Trap 
with mass spectrometry and qualitative proteomics, and secondly, through 
characterisation of cellular phenotypes upon perturbation of Sec8. The model 
organism Schizosaccharomyces pombe was chosen for its fast generation time 
and genetic tractability, and because whilst a large amount of research 
surrounding the exocyst has been performed in other yeast species, it is 




2.1. Yeast Culture and Genetics 
2.1.1. Media and Culture 
The list of Schizosaccharomyces pombe strains used in this study is shown in 
Appendix Table 1. Yeast cells were maintained and cultured as described in 
(Moreno et al., 1991). The composition of the rich medium (YE5S), minimum 
medium (EMM), freezing medium (YFM), mating medium (ME4S), supplements 
and stock solutions is described in Appendix Tables 2-5. Plates contained 20 % 
agar (VWR Chemicals). Most experiments were carried out in YE5S, but EMM 
was used for auxotrophic selection and for microscopy (see below). 
Cells were woken up (from storage at -80 oC) on YE5S plates, and incubated at 
27 oC for 2- 8 days. Cells were inoculated into sterile glass flasks containing 50-
200 mL of either YE5S, or EMM supplemented with amino acids. Flasks were 
shaken at 180-200 rpm. All experiments were carried out at 27oC. To ensure cells 
were exponentially growing prior to starting experiments (mid-log phase in YE5S 
= 1.106- 1.108 cells/ mL; in EMM= 1-6.104 cells/ mL), cell density was measured 
with a spectrophotometer, and the OD600nm value was converted into a cell 
concentration from an existing lab standard curve.  
The temperature-sensitive sec8-1 mutant was obtained from the 
Balasubramanian lab, and is the only published sec8 mutant in S. pombe (Wang 
et al., 2002). Sequencing has not been performed, so the nature of the 
mutation(s) in the gene is unknown. 
2.1.2. Crossing Strains 
To cross strains of opposite mating types, small pellets of both strains were taken 
from a YE5S plate, mixed together with 10 µl of sterile water, and spread on an 
ME4S plate. Cells were left to conjugate and sporulate at 27°C for 2 days. A small 
pellet of these cells was mixed with 200 µl of sterile water, and 10 µl of this mixture 
was transferred to a new YE5S plate. Using a tetrad dissector (MSM 400, Singer 
Instruments) up to 18 asci were separated into a grid. Asci were once again left 
at 27°C to allow endolysis of the ascus wall. The four spores of each ascus were 
then further dissected, and the plate left to grow at 27°C for 4-5 days. Cells were 
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replicate-plated onto selective conditions. Geneticin was used in YE5S at a final 
concentration of 100 µg/ml. The sec8-1 mutant is temperature-sensitive, and 
clones were therefore identified by an absence of growth at 36oC. The coxIV-
dsrfp strain (used for visualising mitochondria) was originally constructed by 
insertion of this cassette at the leu1 locus (Chiron et al., 2008), and CoxIV-
dsRFP-positive clones were selected on EMM containing no leucine. Only tetrads 
that yielded four colonies and that displayed normal allelic segregations were 
selected. Two successful clones were re-streaked on selection, assigned a strain 
collection number and frozen in YFM at -80°C until required. 
2.2. GFP-Trap 
2.2.1. Protein Extraction and Immuno-precipitation 
Two independent replicate GFP-Trap experiments were carried out (R1 and R2). 
The methodology is summarised in Figure 3.The experiments were performed on 
two different strains: a strain in which a gfp cassette was inserted in the 3 region 
of the endogenous sec8 gene, thus expressing Sec8-GFP at its endogenous level 
(Wang et al., 2002). These cells show no apparent growth or morphological 
defect that may suggest that the GFP fusion protein affects the function of Sec8. 
A wild-type strain was also used, as a control.  
The protein extraction prior to the GFP-TRAP was performed as in Jourdain et 
al., 2012 .In brief, approximately 0.5-1x109 cells were pelleted by centrifugation 
(4000 rpm, 5 min, room temperature) and re-suspended in 50 µl of Extraction 
Buffer (EB - see Appendix Table 6). Cells were lysed using the mechanical action 
of acid-washed glass beads in a ribolyser (FastPrep FP120 apparatus, Savant. 
Co.). They were ribolysed (4oC) for two 25 second periods at 5.5 power, with a 
one-minute interval. The base of the 1.5 ml microcentrifuge tubes containing the 
ribolysed cells were pierced using a hypodermic needle (21G x 1 1/1”), and the 
solution was centrifuged (4oC ) at 10,000rpm for 60 seconds into a new 1.5 ml 
microcentrifuge tube (Figure 4). This yielded whole cell extracts (WCE). Protein 
concentrations were determined by Bradford assay (BioRad, California), and 40 
μg of WCE was retained for western blotting.  
For each reaction, 50 µl of GFP-Trap®_A beads (Chromotek GmbH, Germany) 
were centrifuged to remove the 20% ethanol suspension. Beads were then  
S. pombe
sec8-gfp
















Figure 3: An illustration of the GFP-Trap methodology. 
Whole cell extracts (WCE) were collected. The WCE was then incubated with 
pre-coated Chromotek GFP-Trap beads at 4°C for 18 hours. Proteins were washed 
and eluted, before being analysed by mass spectrometry and subsequent comparison 
to the S. pombe proteome. Duplicate experiments were performed for both of the 







Figure 4: The whole cell extract (WCE) filtering process
Diagram illustrating the filtering process used to extract whole cell extract (WCE). After 
cells were ribolysed using glass beads, the microcentrifuge tube was pierced, and the 
supernatant centrifuged into a new tube.  
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washed once in 500 µl of EB, and re-suspended in 50 µl of EB. The washed 
beads were then mixed with 10 mg of WCE. The solution was left to rotate at 4°C 
overnight (approximately 18 hours). The immunoprecipitated proteins were 
washed twice in 400 µl of EB, and 10% of the final volume was retained for 
western blotting (IP). The remaining protein/bead complexes were stored at -
80°C. These were then boiled in laemmli buffer (to elute the proteins), and 
analysed by LC-MS/MS (liquid chromatography – tandem mass spectrometry) at 
the University of Bristol Proteomics Facility.  
2.2.2. Western Blotting  
Whole cell lysates and the IP solutions were separated on a 10% polyacrylamide 
gel using SDS-PAGE (see Appendix Table 7). Gels were transferred to methanol-
activated PVDF membranes overnight at 30 V. Membranes were blocked in PBS 
5% nonfat milk, then incubated with 1:1000 anti-GFP antibody (Sigma-Aldrich, 
Cat #11814460001) for 60 minutes at room temperature, and washed three times 
in PBS 0.1% Tween. The membranes were then incubated with 1:40,000 anti-
mouse IGG secondary antibody (Sigma-Aldrich, Cat #A9044) for 60 minutes at 
room temperature. All antibodies were diluted in PBS 2.5% nonfat milk. 
Membranes were developed using Amersham ECL Western Blotting Detection 
Reagent (GE Healthcare Life Sciences, Cat #RPN2106). The membrane from 
replicate one was developed for 5 minutes, and the membrane from replicate two 
was developed for 60 minutes. 
2.2.3. Proteomics Analysis 
Proteins were identified by the Proteomics Facility using a Sequest search 
against the S. pombe Uniprot database. Low confidence peptides with less than 
5% false-discovery rate (FDR) were removed. These identified proteins were 
received as a spreadsheet which detailed the statistics for each protein hit, such 
as the number of proteins detected, number of unique peptides detected, area 
and percentage coverage. A ‘score’ for each protein hit was also given - this 
considers several variables and gives an overall indication of the quality of a hit 
(the higher, the more significant). In the wildtype strain, replicate 1 had 2182 
protein hits and replicate 2 had 1886 protein hits. In the sec8-gfp strain, replicate 
1 had 2210 protein hits and replicate 2 had 2170 proteins hits. These 
subsequently needed to be filtered to eliminate false positives. Figure 5 shows 
Figure 5: Thresholding of the GFP-Trap data identified 136 double-positive Sec8-interacting proteins
All protein hits were collated in a Microsoft Excel spreadsheet. The filtering schematic shown above was used to eliminate false-positive and 
low-confidence hits from the data, in order to produce a list of high-confidence interacting proteins (see in text for further details). This analysis 
identified 136 double-positive Sec8-interacting proteins. 
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how this data was filtered to produce a list of high-confidence hits. Firstly, the 
proteins identified in the two replicate wildtype GFP-Traps were combined, and 
this list was designated ‘Negatives’ – proteins that were pulled down by the anti-
GFP antibody in the absence of GFP (n=4068). The data from each sec8-gfp 
replicate was initially analysed separately. Both were compared against the 
Negatives list to remove any non-specific hits; any proteins detected exclusively 
in the Sec8-GFP Traps were considered true positives, and any proteins which 
were in the Negatives list, but showed at least a 2.5-fold increase in score in the 
Sec8-GFP Trap were also considered true positives. This produced a list of ‘True 
Positives’ for each replicate (n=649 and n=874 for R1 and R2 respectively). Any 
protein with a score of 0 was then removed from the true positives lists, reducing 
them to R1 n=415 and R2 n=613. These two lists were compared, and any protein 
which appeared in both lists was deemed a ‘Double-Positive’ (n=136). These 
double-positives were considered high-confidence Sec8-interacting proteins, and 
were used for subsequent analyses.  
2.3. Cell Biology  
2.3.1. Microscopy and Image Acquisition 
For microscopy, cells were grown and observed in EMM medium supplemented 
with amino acids. This was for two main reasons: firstly, EMM creates less 
fluorescent background than YE5S. Moreover, CoxIV-dsRFP is under the control 
of a repressible nmt promotor which is shut off in the presence of thiamine (Chiron 
et al., 2008). Thiamine is naturally present in YE5S, but not in EMM. Therefore, 
to be able to visualise the CoxIV-dsRFP signal, cells were cultured in EMM for at 
least 18 hours.   
An agarose pad was prepared by pipetting 800 µl of EMM 2% agarose in an 
imaging chamber gasket (20-mm diameter, 0.5-mm depth, CoverWell™, 
Molecular Probes). One millilitre of cells was concentrated by centrifugation 
(13000 rpm, 30 sec) and 5 µl was spread on the polymerised agarose pad. The 
chamber was then sealed with a 22 × 22 mm glass coverslip. 
When visualisation of the cell’s border was required, 0.7 µl of Calcofluor White 
(fluorescent brightener 28, Sigma-Aldrich) prepared at 5mg /mL in water was 
pipetted on the top of the cells before the coverslip was sealed. 
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Mitotracker Red CMXRos (Molecular Probes) was dissolved in DMSO at a 
concentration of 1 mM. This stock solution was diluted in EMM (supplemented  
with amino acids) to 1 µM. Nine hundred microlitres of cells was incubated with 
100 µl of this 1 µM Mitotracker dilution for 15-30 minutes. Cells were washed 
three times in EMM supplemented with amino acids, placed on an agarose pad 
and observed immediately.  
 
Samples were examined using a Zeiss Z1 AxioObserver inverted fluorescence 
microscope, equipped with a motorised stage, in a temperature-controlled 
incubation chamber. Images were captured at 27°C using a 100x, 1.4 NA oil-
immersion lens and a Cool-Snap HQ2 CCD camera (Photometrics) controlled by 
Axiovision software (ZEISS).   
 
To assess nuclear morphology, z-stacks taken through the full depth of the cell 
were acquired, with slices 0.5 µm apart. To assess mitochondrial morphology, z-
stacks through the full depth of the cell were acquired with slices 0.4 µm (replicate 
1) or 0.5 µm (replicate 2) apart. To monitor mitochondrial dynamics, time-lapse 
imaging was performed. Each field of view was imaged every 30 seconds for 10 
minutes. At each timepoint, a Z-stack through the full depth of the cell was 
acquired with slices 0.5 µm apart. 
2.3.2. Image Analysis  
All image analysis was performed using ImageJ (Schindelin et al., 2012), and 
counts and measurements were exported to Microsoft Excel. 
For the analysis of nuclear and cellular volume, the two z-stack slices at which 
the nucleus had the widest diameter (presumed to be the centre) were merged 
to create a maximum intensity projection using ImageJ. Measurements were then 
taken using this image. The cell was treated as a capsule, and the nucleus as a 
prolate ellipsoid (Neumann et al., 2007). Measurements were taken as shown in 
Figure 6A and 6B, and volumes were calculated using simple geometries. For the 
analysis of nuclear positioning, measurements were taken as shown in Figure 
6C. They were used to calculate the true centre of the cell, and the centre of the 
nucleus. The difference between these two values was calculated in 
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Figure 6: Geometric measurements used to determine cellular and nuclear 
properties
Diagram illustrating the measurements taken and formulas subsequently used to 
determine (A) cell volume (B) nuclear volume and (C) nuclear position. 
(A) For cell volume, S. pombe cells were treated as capsules. "L" was measured as 
the length along one side between the cell tips. "D" was measured as with the width 
just before the cell tip. To calculate volume, these measurements were fed into the 
equation shown above.  
(B) For nuclear volume, the nucleus was treated as a prolate ellipsoid. "A" was 
measured as the longest nuclear width (in any direction). "B" was measured as the 
perpendicular width to A. To calculate volume, these measurements were fed into the 
equation shown above. 
(C) "C" and "D" were measured as the length from the centre of the cell tip  to the 
nuclear envelope, from either end respectively. "E" was measured as the width of the 
nucleus parallel to the length of the cell, between "C" and "D". The centre of both the 
cell and the nucleus were calculated using the equations shown. *For this equation, 
the longest value out of "C" or "D" was used here.
A ÷ 2 = a
B ÷ 2 = b
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For mitochondrial analysis, images were exported to ImageJ and the out of focus 
slices removed. A maximum intensity projection was created for each timepoint. 
Mitochondrial morphology and fission/fusion events were scored manually from 
each maximum intensity projection. 
2.3.3. Statistical Analyses  
Frequency counts (for mitochondrial morphology) were assessed using Chi-
Squared analysis. All quantitative data (mitochondrial fission/fusion evens) were 
tested for normality using the Shapiro-Wilk test, and parametic (t-test) or non-
parametric (Mann-Whitney/U test) tests applied, as appropriate, using the 





Identifying Novel Interaction Partners of 
the Exocyst Member Sec8 
The fission yeast Schizosaccharomyces pombe has a short generation time, a 
relatively small genome, and is genetically tractable. Indeed with a completely 
sequenced and well-annotated genome, S. pombe is easy to manipulate (Wood 
et al., 2002). Its small size (approximately 2-3 μm by 7-10 μm) and uniform rod 
shape make morphological defects easy to observe. S. pombe is also bigger than 
the budding yeast S. cerevisiae, making its cytology easier to observe by light 
microscopy. Its proteome is also much simpler than that of higher eukaryotes. 
Importantly the exocyst complex is conserved in S. pombe, with four of its 
members sharing ~20% sequence identities and aligning along their full length 
with their orthologues in other organisms (Wang et al., 2002), indicating that the 
exocyst plays important conserved roles across eukaryotic evolution. Taken 
together, these qualities make S. pombe an ideal model organism to investigate 
and characterise cellular roles of the exocyst complex. 
3.1. GFP-Trap Identifies 136 Interaction Partners of Sec8 
As a first step to test the hypothesis that there are uncharacterised cellular roles 
for Sec8, I sought to identify novel interaction partners of Sec8 in S. pombe that 
may either shed some light on known mechanisms, or indicate new cellular 
functions of Sec8.  
GFP-Trap is one of several of techniques that allow the identification of previously 
unknown interaction partners. Others include yeast two-hybrid, pulldown assays 
using recombinant proteins, and tandem affinity purification (TAP-tagging). GFP-
Trap is a versatile tool to investigate GFP-fusions and their interacting partners 
(Agarwal et al., 2007; Schermelleh et al., 2007; Trinkle-Mulcahy et al., 2008; 
Frauer et al., 2009). Its high affinity and the lack of heavy and light antibody chains 
is a major advantage over conventional immunoprecipitation. Moreover, it is 
much less time-consuming than yeast-two hybrid. 
The technique requires a cell line that is expressing the protein of interest (POI) 
tagged with GFP. Whole cell extract is incubated with commercially-available 
agarose beads that have been pre-coated with GFP antibody. The antibody-GFP-
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POI complexes (along with proteins that are interacting with the POI) are eluted 
by boiling. These proteins are then identified by mass spectrometry and 
subsequent comparison to the organism’s proteome. 
GFP-Trap was performed to identify Sec8 interacting partners in S. pombe. 
Duplicate samples of wild type S. pombe and cells expressing Sec8-GFP under 
the control of the native promoter (Wang et al., 2002) were subjected to GFP-
Trap. To confirm that Sec8-GFP could be extracted successfully, immunoblotting 
of whole cell extract and GFP-Trap samples (IP) was performed with anti-GFP 
antibody. Western blotting revealed a band of the appropriate size (~150 kDa, 
Figure 7), in both the whole cell extract (WCE) and the precipitate (IP) from post-
incubation with the GFP-TRAP beads, indicating successful pull-down of the 
fusion protein. No bands were detected in a WT strain lacking the fusion protein, 
indicating specificity of the antibody. The identity of the smaller bands in the IP 
sample is unknown, but is hypothesised to be proteolysis products. However, 
these were not detected in the WT control and therefore are likely to be specific 
to Sec8-GFP. 
Samples from two independent replicates were therefore taken forward, and 
analysed by mass spectrometry to identify the proteins that had been pulled down 
alongside the GFP fusion protein. This identified 2000+ protein hits in each 
sample. These were filtered further to produce a list of high-confidence hits, as 
illustrated In Figure 5. Proteins that were pulled down by the anti-GFP antibody 
in the absence of GFP (n=4069) were designated “negatives”. The hits from each 
Sec8-GFP replicate were filtered against the Negatives list to remove non-
specific hits. Proteins detected exclusively in the Sec8-GFP Traps were 
considered true positives, as were proteins in the Negatives list that showed at 
least a 2.5-fold increase in score in the Sec8-GFP Trap. Data from the two Sec8-
GFP replicates were combined, and the 136 proteins that appeared in both lists 
- termed ‘Double-Positive’ - were considered to be high-confidence Sec8-
interacting proteins (listed in Table 2, scores in Appendix Table 8). Many of these 
‘double-positives’ are likely indirect interactors due to the nature of the technique, 
and will need to be confirmed by alternative techniques (see discussion).  
  
Figure 7: The presence of Sec8-GFP was successfully immunodetected
Either wildtype or sec8-gfp cells were lysed to produce whole cell extract (WCE). This 
WCE was then incubated with GFP-Trap beads, producing a bead precipiate. WCE 
and 10% of the bead precipitate (IP) were subjected to western blotting and probed 
with anti-GFP antibody. Blots are shown for each of the two replicate GFP-Traps, 
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Table 2: The GFP-Trap identified 136 double-positive Sec8 interacting proteins 2  
Uniprot Accession Gene Name Uniprot Accession (cont.) Gene Name (cont.) 
O74562 sec8 Q9USJ4 nte1 
O74846 sec6 Q9USZ2 mtr10 
O75006 sec15 O42963 nup44 
O13705 sec10 P33277 gap1 
O94598 sec5 O42854 bbc1 
O14226 exo84 Q9P792 nbr1 
Q10339 exo70 Q9P7H8 ecm29 
Q10411 spo15 Q10222 pta1 
O14065 tcb1 O42998 sip1 
Q10324 sec3 Q1MTQ5 mug89 
Q9UUE2 csx2; cnt5 O94548 Unassigned 
Q1MTR3 vid27 Q1MTN8 Unassigned 
O14072 cta4 Q9UTF8 ugo1 
Q09891 Unassigned O74738 set10 
Q09857 uso1 O74547 bit61 
O74319 taf73 O74541 Unassigned 
O13791 slt1 O14130 Unassigned 
Q9UT35 gdp1 Q9P382 nup82 
O74369 css1 Q9UT67 imt1 
Q10064 tra2 Q9UQX0 sod2 
O14283 prr1 P87114 fft1 
P78847 nup186 O42930 vps10 
O14290 Unassigned O74481 pdi5 
O74349 rkr1 O94516 pex16 
Q10435 Unassigned O94520 emc4 
Q7Z9H9 fig4 P78871 rst2 
O42901 orm1 O14068 Unassigned 
Q10243 vps26 Q9P7J5 yta4 
O13282 taf5 Q9UTL2 klp8 
Q10496 gyp51 Q10361 etp1 
O14197 Unassigned O59747 pdf1 
Q9P782 aha1 Q8WZK2 its8 
O74534 sly1 Q9UTK6 Unassigned 
O60081 trm72 O94689 yme2 
P50524 rpn12 Q9Y7N9 Unassigned 
Q9P7W8 rsc9 Q9UUI8 pet1 
Q9Y7K2 tor2 P27584 gpa1 
O14301 aip1 Q09922 Unassigned 
O74925 pep3 Q09787 Unassigned 
Q9UTH0 nup132 O42929 tma22 
O42954 mbx1 O94691 jmj3 
Q9Y7J8 psy2 Q10347 any2 
Q9P7X5 ppk32 Q09830 Unassigned 
O14340 Unassigned O42973 Unassigned 
O94374 imp1 Q1MTQ1 tea2 
Q9UTK7 dsc2 O74308 gsf1 
Q9UUH0 Unassigned Q9US60 klp3 
Q10331 nup107 O14002 mak2 
O94712 gid1; vid30 Q9UTK4 nup189 
O13897 fsh2 Q10245 ifa38 
Q09849 arp42 Q92359 puf4 
Q9P7R8 gea1 Q9UT38 vps16 
O74773 msh2 Q9UTN3 cid14 
Q10429 cnd3 O74823 red5 
Q09779 tho2 P78875 tpp1 
Q9C100 ogm2 O43092 oxa102 
Q10108 edc1 Q10093 Unassigned 
P78953 mid1 Q10366 pik1 
O74504 Unassigned P87234 gyp3 
O13636 tim50 O60108 cbh2 
Q09743 ste20 O94733 Unassigned 
Q9P7W0 Unassigned O14076 mpp6 
Q10165 cnt6 Q9HGN7 sec63 
Q10268 mac1 O59741 prt1 
P00046 cyc1 Q76PC3 mme1 
O14188 rng2 Q10110 rrn3 
O59712 Unassigned Q9Y802 lsd1 
Q09682 pre9 O13960 ecm33 
 
                                                          
2 The Uniprot accession ID and gene name is listed for each double-positive Sec8-interacting 
protein. Interactors are listed from highest score (averaged across both Sec8-GFP replicates) to 
lowest. “Unassigned” is used when there is no gene name assigned in the PomBase NAR 
Database entry for that protein (Wood et al. 2012). 
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Of the double-positive proteins identified, the highest scoring hit was Sec8 itself, 
with both a score and number of unique peptides 2.5 times higher than any other 
hit. As Sec8 was the bait protein, this is expected. The other members of the 
exocyst complex were the next highest scoring hits, providing evidence for the 
success of this approach.  
To examine the pathways and processes that the putative interaction partners 
were involved in, each of the 136 double-positives was analysed by functional 
annotation clustering according to gene ontology using DAVID (Huang et al., 
2009a, 2009b). Grouping of the Sec8 interaction partners by cellular 
compartment (GOTERM_CC_5) showed that the most significant clusters include 
‘exocyst complex’, ‘Vesicle’, ‘Microtubule’, ‘Cortical Actin’ and ‘Golgi’ (Figure 8A). 
Grouping by biological process (GOTERM_BP_5) showed that the most 
significant processes were exocytosis and vesicle tethering, and that within the 
top 20 terms there was also endosomal transport, vesicle fusion and protein 
targeting to membrane (Figure 8B). 
These top clusters are not surprising, as they all align with Sec8’s well-
documented role in the late secretory pathway. Combined, they are a good 
indication that, to an extent, the GFP-Trap has been successful. However, in 
addition to these known interaction partners, the GFP-Trap data revealed an 
unexpected novel association of Sec8 with proteins found in the nucleus (Figure 
8, blue bars) and in mitochondria (Figure 8, red bars). 
 
3.2. Clustering of the Sec8 Interaction Partners Reveals 
Nucleus-associated Proteins 
Further inspection of the grouped interactors revealed several nucleus-
associated clusters which were intriguing because they did not necessarily align 
with the exocyst’s documented roles. When grouped by cellular compartment 
(CC), ‘Nuclear envelope’ and ‘ER’ were the clusters with the highest significance 
after ‘exocyst’, and indeed there were several other nuclear-related clusters 




Figure 8: Gene ontology grouping of the Sec8-interacting proteins reveals both 
expected and novel clusters. 
Double-positive interacting proteins were clustered according to either (A) cellular 
compartment, using GO TERM CC_5 or (B) biological process, using GOTERM BP_5. 
Typically, the name of each cluster was taken from the GO_TERM in that cluster with the 
highest number of proteins, but in some cases a summary name was manually chosen. 
Significance was calculated as the –log10 of the p value calculated for that cluster. 
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‘nucleoplasm’ and ‘chromosome’. Grouping by biological process (BP) also 
revealed significant nuclear-related clusters (highlighted blue in Figure 8B), with 
nuclear transport’ the third most significant cluster, and ‘transcriptional regulation’ 
the fifth. Both had a higher significance than ‘vesicle fusion’, which is one of the 
exocyst’s most characterised roles. ‘Chromatin organisation’, ‘mitotic cytokinesis’ 
and ‘nuclear division & chromosome segregation’ were also in the top 20.  
To examine the localisation of these nucleus-associated Sec8-interacting 
proteins more closely, I retrieved those with the following CC GO annotations: 
‘Nuclear envelope’, ‘nuclear pore’ and ‘nucleoplasm’. These are listed with their 
respective scores in Figure 9A. Of the Sec8-interacting proteins in the ‘nuclear 
envelope’ cluster, eight also fall within the ‘nuclear pore’ cluster (Figure 9A, 
highlighted red). All proteins have also been illustrated in Figure 10 to give some 
indication of their localisation in situ. 
For each CC GO-term, I calculated what percentage of the total number of 
proteins in that term were detected as double-positive interactors in this 
experiment (Figure 9B). 8.5% of Nuclear Envelope proteins, 2.7% of 
Nucleoplasm proteins and 16% of Nuclear Pore proteins were detected. This 
showed firstly that the nuclear envelope was better represented than 
nucleoplasm, which could perhaps suggest that a greater interaction is occurring 
outside the nucleus and at the periphery. It also showed that ‘nuclear pore’ was 
the most represented cluster; 16% of components were detected as double-
positive interacting partners, although below the threshold a further 35% were 
detected as showing a positive score increase in at least one replicate. I therefore 
looked again at more specific CC GO-terms to see which structural components 
of the nuclear pore complex (NPC) were detected: outer ring, cytoplasmic 
filaments and basket (Figure 9C). The GFP-TRAP detected 30% of the Outer 
Ring proteins, none of the nuclear basket proteins and 50% of the Cytoplasmic 
Filaments. The cytoplasmic filaments are therefore the best represented structure 
within the nuclear pore complex. 
Some of the Sec8-interacting proteins detected by the GFP-TRAP therefore 
indicate a putative novel interaction between Sec8 and the nuclear envelope, 
specifically with the nuclear pore complex and nuclear import/export. 
  
 















Vid27 Family Protein SPBC1685.14c 11.8 35.5 6.8 22.0 
Nup186 SPCC290.03c 6.8 18.8 6.0 20.4 
Nup132 SPAC1805.04 1.9 21.2 0 2.4 
Mid1 SPCC4B3.15 0 12.9 0 4.1 
Imp1 SPBC1604.08c 5.1 16.6 0 5.1 
Nup107 SPBC428.01c 5.4 19.1 0 1.7 
Mtr10 SPBC11G11.07 0 10.6 0 2.8 
Nup44 SPBC19G7.15 2.2 10.6 0 2.6 
Nup82 SPBC13A2.02 0 8.1 0 1.7 
Nup189 SPAC1486.05 0 2.8 0 1.9 
Sec63 SPBC36B7.03 0 1.6 0 2.0 
Nucleoplasm 
Tra2 SPAC1F5.11c 3.4 35.3 0 6.7 
Taf73 SPBC15D4.14 8.4 23.7 5.5 23.0 
Taf5/Taf72 SPCC5E4.03c 7.6 22.3 0 7.9 
Imp1      
Arp42 SPAC23D3.09 0 8.6 2.9 10.6 
Pta1 SPAC1071.01c 1.7 8.0 0 4.3 
Red5 SPBC337.12 0 2.3 0 2.3 
*Also present in CC_Nuclear Pore  
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Figure 9: Analysis of the nuclear-related Sec8-interacting proteins reveals 
components of the nuclear pore complex
(A) Table detailing the Sec8-interacting proteins with the nuclear CC_GO annotations 
shown. Proteins that also had the annotation “CC_Nuclear Pore” are highlighted in 
red. The protein scores for each replicate are shown, rounded to 2 d.p. Theses scores 
are an overall measure of the quality of a protein hit (see text for details). Where a 
protein appears in both groups, its details have not been listed a second time.
(B) and (C) are graphs demonstrating the representation of different CC_GO terms 
within the Sec8-interacting proteins. The number of proteins detected is shown as a 
percentage of the total number of proteins in the genome with that annotation. (B) is 
examining differenct nuclear structures, and (C) is examining specific components of 
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Figure 10: Illustration of the nuclear envelope, nuclear pore and nucleoplasm 
components captured by the Sec8 GFP-Trap. 
Proteins with the GO annotation "CC_Nuclear Envelope" or "CC_Nucleoplasm" are 
diagrammed above, and labelled with red text.  Proteins labelled in grey were not 
detected in the GFP-Trap, but have been shown to give context. Components of the 
outer nuclear membrane (ONM) are shown in red, the inner nuclear membrane (INM) 
in blue, the nuclear pore complex in pink and the nucleoplasm in green. Annotations 
have been added to give some indication of protein function, where known. The 



























3.3. Perturbation of Sec8 Affects Nuclear Volume, but Not 
Positioning 
As the proteomics data suggests an interaction with the nuclear envelope, I 
sought to examine the nature of this interaction by examining nuclear phenotypes 
in the sec8-1 mutant (Wang et al., 2002). This temperature-sensitive mutant 
exhibits a severe septation defect at all temperatures, but more so at higher 
temperatures (36°C). The population displays a high septation index even at the 
supposedly permissive temperature (27°C, which will henceforth be referred to 
as the semi-permissive temperature). However, as it is currently the only existing 
sec8 mutant S. pombe strain, it was therefore used in this study.  
I created a sec8-1 strain expressing nuclear envelope marker Pom152-GFP. As 
it was not detected as a Sec8-interacting protein, it is expected that its localisation 
will not be affected by mutation of Sec8, making it a suitable choice for a marker. 
Cells were stained with calcofluor (to mark the cell wall) and live-imaged at the 
semi-permissive temperature, alongside wildtype cells expressing Pom152-GFP. 
From these images, measurements were taken and used to calculate the nuclear 
to cellular volume (N/C) ratio, and the position of the nucleus in relation to the cell 
centre.  
Visual comparison of sec8-1 pom152-gfp to wildtype pom152-gfp showed no 
immediately apparent phenotypes (Figure 11A). In both strains, Pom152-GFP 
appeared to be homogenously distributed along the nuclear periphery. Compared 
to WT cells, sec8-1 nuclei showed no obvious defects in size or morphology. 
However, measurement of the Nuclear/Cellular (N/C) ratio revealed that there is 
in fact a subtle increase in the mean N/C ratio in the sec8-1 cells (Figure 11B) 
(mean N/C ratio WT= 0.10 +/-0.003, n=70 cells; sec8-1 = 0.11 +/-0.003, n=62 
cells). 
In fission yeast, the position of the septum is defined by the position of the nucleus 
in interphase (Daga et al., 2005). I speculated as to whether the severe septation 
phenotype observed in the sec8-1 mutant could be linked to a defect in nuclear 
positioning. To test this possibility, I measured the position of the nucleus relative 
to both cell ends in WT and sec8-1 cells (see Methods). The offset of the nucleus 
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Figure 11: Mutation of Sec8 mildly affects nuclear volume, but does not affect 
nuclear positioning
(A) Images of both wildtype and sec8-1 cells expressing the nuclear envelope marker 
Pom152-GFP. Cell peripheries have been stained using calcofluor. Scale bar 
represents 5 μm. (B) Nuclear to cellular volume ratios for both wildtype (n=70) and 
sec8-1 (n=62) cells (see text for details on calculation). (C) Frequency distribution 
showing the displacement of the nucleus from the cell centre, measured as % of cell 




were binned into one of 11 categories and displayed in a frequency distribution 
(Figure 11C). The distributions of the wildtype and sec8-1 populations appear 
similar, so mutation of sec8 does not appear to affect nuclear positioning.  
These preliminary data indicate that mutation of sec8 mildly affects nuclear 
volume, but does not affect nuclear positioning. However as only one replicate 
was performed for these datasets, it was not possible to perform statistical 
analyses to confirm this. Due to time constraints of this study, and the fact that 
the nuclear phenotype observed was relatively mild, I decided to focus on 
pursuing the mitochondrial avenue of investigation from this point onwards. 
 
3.4. Clustering of the Sec8 Interaction Partners Reveals 
Mitochondria-associated Proteins 
As well as revealing nuclear-related clusters, inspection of the grouped Sec8-
interacting proteins also revealed several mitochondrial-associated clusters. As 
no interaction between the exocyst and the mitochondria has been previously 
described, I decided to investigate this putative novel association further.  
When the Sec8-interacting proteins were grouped by cellular compartment (CC), 
‘Mitochondrial membrane’ was the cluster with the sixth highest significance 
(highlighted red, Figure 8A). It placed higher than clusters such as ‘Golgi’, 
‘Cortical Actin Cytoskeleton’ and ‘Plasma membrane’ which link to the exocyst’s 
know roles in the late secretory pathway. Grouping by biological process (BP) 
showed that ‘Lipid Metabolism’ and ‘Mitochondrial Transmembrane Transport’ 
both place in the top 20 significant clusters (highlighted red, Figure 8B).  
To further examine the localisation of the mitochondrial Sec8-interacting proteins, 
I retrieved all with the following CC GO annotations: ‘Mitochondrial outer 
membrane’, ‘mitochondrial inner membrane’ and ‘mitochondrial matrix’. These 
are listed with their respective scores in Figure 12A, and have been illustrated in 
Figure 13 to give some indication of their localisation in situ. For each CC GO-
term, I calculated what percentage of the total number of proteins in that term 
were detected as double-positive Sec8 interactors (Figure 12B). 6.4% of outer 
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Figure 12: Analysis of the mitochondria-related Sec8-interacting proteins 
reveals components of the mitochondrial fusion mahcinery.
(A) Table detailing the Sec8-interacting proteins with the mitochondrial CC_GO 
annotations shown. The protein scores for each replicate are shown, rounded to 2 d.p. 
Theses scores were provided by the Bristol Proteomics facility, and are an overall 
measure of the quality of a protein hit (see text for details). 
(B) and (C) are graphs demonstrating the representation of different GO terms within 
the Sec8-interacting proteins. The number of proteins detected is shown as a 
percentage of the total number of proteins in the genome with that annotation. (B) is 
examining different mitochondrial structures, and (C) is examining BP_GO annotations 
regarding mitochondrial fission and fusion.
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Mitochondrial Inner Membrane Fusion
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Css1 SPBC32F12.01c 7.1 24.9 1.9 17.5 
Ugo1 SPAC1B2.02c 0 8.1 0 2.6 




Tim50 SPBC17A3.01c 0 8.9 0 7.3 
Cytochrome C SPCC191.07 0 2.1 2.1 13.5 
Etp1 SPAC22E12.10c 0 5.4 0 2.1 
Mitochondrial RNA-
binding Protein  SPBC83.05 0 4.1 0 2.2 
Oxa102 SPAC23D3.09 0 8.6 2.9 10.6 
Mme1 SPAC1071.01c 1.7 8.0 0 4.3 
Mitochondrial 

























Figure 13: Illustration of the mitochondrial envelope proteins captured by the Sec8 GFP-Trap
Double-positive Sec8-interacting proteins were sorted according to gene ontology terms using the DAVID software. Proteins with the GO 
annotation "CC_Mitochondrial Envelope" are diagrammed above. Annotations have been added to give some indication of protein function, 
where known. Outer mitochondrial membrane (OMM) proteins detected are shown in red, and inner mitochondrial membrane (IMM) proteins 




















proteins were detected. This showed that the mitochondrial outer membrane was 
the best represented cluster, and suggests that this is perhaps where Sec8’s 
interaction is focused. Another possibility is that insufficient permeabilisation 
during the GFP-TRAP resulted in the entire mitochondrial membrane being pulled 
down (see discussion for further consideration of these two possibilities).  
I further noticed that several of the putative mitochondrial Sec8-interacting 
proteins were involved in mitochondrial organisation, so I retrieved all the 
interactors with the BP GO annotations: ‘mitochondrial fission’ and ‘mitochondrial 
fusion’. Again, I calculated the percentage representation of each cluster as 
described above (Figure 12C). This showed that none of the proteins required for 
mitochondrial fission were detected, but 2/3 of the proteins required for 
mitochondrial fusion were high-confidence Sec8 interactors – Ugo1 and 
Msp1/Yta4. I therefore retrieved interactors with the annotations ‘mitochondrial 
outer membrane fusion’ and ‘mitochondrial inner membrane fusion’. Surprisingly, 
100% of the proteins in each cluster were detected. Ugo1 and Msp1 are 
responsible for fusion of the outer and inner membranes respectively. This 
provides the first evidence for a possible mitochondrial role for Sec8, more 
specifically in the context of mitochondrial fusion. 
3.5. Perturbation of Sec8 Causes a Change in Mitochondrial 
Morphology 
As the proteomics data suggests an interaction between Sec8 and mitochondria, 
to explore this further I examined mitochondrial morphology upon perturbation of 
Sec8. 
I first attempted to visualise mitochondria in live cells using the Mitotracker dye 
(data not shown). The mitochondria labelled well in the WT cells, but the staining 
was very uneven among sec8-1 cells, even in several replicates. The reason for 
this was not clear but possibly indicates a functional mitochondrial defect. 
Nevertheless, this complicated the live-imaging of the mitochondria. To overcome 
this issue, I instead observed WT and sec8-1 cells that expressed CoxIV-dsRFP 
– the S. cerevisiae N-termical targeting sequence of cytochrome oxidase subunit 
IV fused to RFP, which serves as a mitochondrial marker (Yaffe et al., 2003; 
Chiron et al., 2008) . These cells were live-imaged at the semi-permissive 
62 
 
temperature. As described previously (Yaffe et al., 1996), WT cells contain 2-5 
long tubular mitochondria that span the length of the cell (Figure 14A). In contrast, 
in sec8-1 cells mitochondria appear to be more fragmented, and often loop 
several times inside the cell. To quantify this phenotype, the images were used 
to manually assign cells to one of six morphology categories from ‘normal’ to 
‘highly fragmented’. The distribution of cells between these morphology 
categories (Figure 14B) was significantly different in the sec8-1 population 
compared to the wildtype (Χ-squared test, p=<0.0001). The proportion of 
category 1 (normal) cells reduced from 57% to 22%. The percentage of category 
2 cells with looped mitochondria increased from 13% to 37%, and the percentage 
of category 3 cells with short mitochondria increased from 18% to 24%. The 
percentage of cells with mitochondria in the final three categories, each 
increasingly more fragmented, were also all increased in the sec8-1 population 
compared to the wildtype. 
This indicates that perturbation of Sec8 clearly affects mitochondrial morphology, 
resulting in a decrease in normal morphology and an increase in the presence of 
both looped mitochondria and shortened fragments.  
 
3.6. Perturbation of Sec8 Causes a Reduction in Mitochondrial 
Fusion 
Mitochondrial morphology is the result of a balance between fusion and fission 
(aka fragmentation) events (Sesaki et al., 1999). The over-fragmentation 
phenotype that I have observed in the sec8-1 mutant could therefore be the result 
of an excess fission, or defective fusion. To test this, I monitored mitochondria 
dynamics by live cell imaging in both sec8-1 and wildtype strains expressing 
CoxIV-dsRFP at the semi-permissive temperature (Figure 15A). The resulting 
time-lapses were used to quantify the average number of fission and fusion 
events per minute in each cell. 
Mitochondrial fission does not appear to be statistically different between WT and 
sec8-1 cells (WT= 0.49 ± 0.035; sec8-1 = 0.36 ± 0.051 fission events per minute 
per cell, unpaired t-test, p = 0.1266, n=10 cells and 13 cells for WT and sec8-1 





Figure 14: Mutation of Sec8 causes an increase in looped and short 
mitochondrial tubules
(A) Images of both wildtype and sec8-1 cells expressing the mitochondrial marker 
CoxIV-dsRFP. Scale bar represents 5 μm. (B) Analysis of mitochondria morphology. 
Cells were imaged in 0.5 μm slices, and maximum intensity projections were created 
from the resulting z-stacks. Mitochondria were scored manually, according to the 
representative scale shown at the top of the panel. Briefly, 1; Considered 'normal'. 
Long mitochondria that run the length of the cell. 2; Mitochondria  are mixture of short 
and long tubules that appear looped. 3; Mitochondria are short tubules, but there are 
no small fragments. 4; Mitochondria are short tubules, and there are some small small 
fragments. 5; Mitochondria are short tubules, and there are many small fragments. 6; 
Mitochondria are virtually all small fragments. On the bottom of the panel, the graphs 
show frequency distributions of different morphology scores in both wildtype and 
sec8-1 populations (n=70 and 91 cells respectively. Chi-Squared test, p<0.0001). 
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Figure 15: Mutation of Sec8 results in decreased mitochondrial fusion
(A) A z-stack was taken of cells expressing CoxIV-dsRFP every thirty seconds for twenty timepoints. The maximum intensity projection of a z-stack 
taken at each timepoint is shown for a representative cell from both wildtype and sec8-1 strains. Fusion events are annotated with red arrows, and 
fission events with blue arrows. Scale bar represents 2μm. (B,C) Graphs to show the number of (B) mitochondrial fisson and (C) mitochondrial fusion 
events per minute, in both the wildtype and sec8-1 strains. In each cell, the number of fission and fusion events at each timepoint was measured (n=10 
cells for wildtype, n=13 cells for sec8-1). This was used to calculate an average number of events per minute, per cell. These values were plotted on 









































In contrast, and in line with the proteomic data, there was a ~50% reduction in 
fusion events in sec8-1 cells compared to the WT (WT= 0.46 ±0.058; sec8-1 
=0.29 ± 0.037 fusion events per minute per cell, Mann-Whitney test, p<0.05, n=10 
cells and 13 cells for WT and sec8-1 respectively, Figure 15C). This therefore 
indicates that whilst fission is unaffected, mitochondrial fusion is greatly reduced 




Together, the results of this study indicate two novel putative interactions for 
Sec8; firstly with constituents of the nuclear envelope (but this was not 
investigated further due to time constraints). Secondly, both the proteomics data 
and initial experiments in vitro indicate a possible interaction with the 
mitochondrial fusion machinery. The author acknowledges that it is highly likely 
that the rest of the exocyst components are involved in these associations (as 
discussed in Section 1.2.2), but for simplicity I will refer to Sec8 alone in this 
discussion.  
4.1. Evaluating the Success of the GFP-Trap 
Whilst the GFP-Trap has seemingly unearthed multiple novel putative interactors 
of Sec8, it is worth discussing the potential caveats of this particular technique. 
There was no perfect control for this experiment. Ideally it would have been 
desirable to have a strain expressing just GFP, but this raises several problems. 
Which promoter do you express it under? How can you get the same level of 
expression as endogenous Sec8? Inserting the gfp cassette in the place of a 
different gene could cause potential off-target effects and skew the results. I 
therefore went with the most straightforward control, which was to use a wildtype 
strain. The GFP-Trap technique has been used multiple times in the lab, so if any 
proteins were being pulled down by GFP specifically then we would have 
consistently detected them across experiments with different fusion proteins. As 
this is not the case, then I can be fairly confident that the wildtype strain acts as 
a sufficient control.  
By nature, this technique cannot give any indication as to whether the detected 
proteins are interacting directly with Sec8, and the results are not quantitative. 
For example, since I pulled down the other members of the exocyst complex as 
expected, it is possible that many of the detected interacting proteins are 
interacting with other members of the exocyst complex, and not Sec8 itself. 
Furthermore, the proteins that do interact with Sec8 are likely pulling their binding 
partners down too. For example, it is possible that Sec8 directly interacts with 
chromatin-associated proteins, and that when these were pulled down during the 
GFP-Trap, components of the inner nuclear membrane (which interact) came 
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with it, along with NPC components. For this reason the results of the proteomics 
data required careful interpretation, and were regarded more as ‘hints’ or 
‘suggestions’ at interactions (with scores giving an indication of the most 
significant interactors), which were in turn used to guide the in vitro studies. A 
technique such as reciprocal co-immunoprecipitation or yeast two-hybrid would 
be required to verify whether any of these interactors directly bind to Sec8, and 
to determine the strength of such an interaction.  
In addition, as discussed in Section 1.4.1, the exocyst appears to exist in multiple 
conformations in different subcellular locations, likely performing different roles. 
In this study, it is perhaps possible that the Sec8-GFP fusion protein used in the 
GFP-Trap may only have been able to assemble with the rest of the complex in 
certain conformations due to the GFP tag. This would mean that the Sec8-
interacting proteins would only be detected for a subset of the cellular functions 
which the exocyst is performing. 
 Nonetheless, GFP-Trap has provided several useful insights in this study, which 
I will henceforth discuss.  
4.2. Novel nuclear roles for Sec8 
Prior to this study, the only described nuclear role of Sec8 was its involvement in 
the DNA repair pathway (outlined in Section 1.3.4), where it acts as a physical 
platform and acts to influence the expression of several signalling and histone 
modifying proteins (Torres et al., 2015). In addition, subpopulations of Sec8 co-
localise with members of the DNA repair pathway inside the nucleoplasm. 
However, to the author’s knowledge no association with the nuclear envelope has 
been described, despite Sec8 being observed to aggregate around the nucleus 
in several studies (Fölsch et al., 2003; Chen et al., 2006; Pohl et al., 2008). This 
GFP-Trap in this study revealed multiple constituents of the nuclear envelope to 
be putative Sec8-interacting proteins. Furthermore, the DAVID analysis showed 
that 70% of the Sec8-interacting proteins in the ‘nuclear envelope’ cluster localise 
to the nuclear pore, which indicates that this is where Sec8’s role is focused. 
Interestingly in yeast, a functional link between nuclear pores and the DNA 
damage repair has been demonstrated; persistently unrepaired DSBs migrate to 
and stably associate with nuclear pores, where it is thought that repair systems 
may be coordinated (Nagai et al., 2008). Given Sec8’s demonstrated role in 
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coordinating DNA repair systems in mammalian cells, it is an intriguing possibility 
that it is also performing this role in yeast, specifically at the nuclear pore 
complex. 
Another possibility is that Sec8 aids in the formation of NPCs. In order to build an 
NPC, a fusion event between the inner and outer nuclear membranes is first 
required to form the ‘pore’ into which NPC proteins are then inserted (Reviewed 
in Rothballer et al., 2013). This fusion event is analogous to the fusion of a 
secretory vesicle to an accepting membrane, so it is exciting to speculate that 
Sec8 may perform a similar role in helping to tether the two membranes. 
However, further examination of the specific NPC components detected in the 
GFP-Trap makes this seem unlikely. The fact that ‘cytoplasmic filaments’ is the 
most represented structural group of the NPC implies that Sec8 is interacting with 
the cytoplasmic face of the pore. However, there are only a total of 2 proteins in 
‘cytoplasmic filaments’, which makes it easier to detect a high percentage 
compared to say ‘outer ring’, which has 7 proteins in total. Yet the fact that none 
of the membrane-bound nucleoporins were detected (see Figure 10) supports 
this deduction, and further indicates that Sec8 is likely interacting with NPCs 
when they are already formed, not during membrane fusion or nucleoporin 
recruitment.  
So if Sec8 is not functioning during NPC formation, perhaps it may perform a 
transport role instead. Two of the other proteins in the ‘nuclear envelope’ cluster, 
Imp1 and Mtr10, are importins - these help to deliver cargo into the nucleus. 
Importin-αs bind cargo in the cytoplasm, whilst importin-βs bind to the importin-
αs and transport the cargo into the nucleus. As discussed in Section 1.1.3, many 
of Sec8’s emerging non-conventional roles show that Sec8 can modify protein 
expression in several cellular contexts, but the mechanism behind this is not 
known. If Sec8 is involved in nucleocytoplasmic transport then this could provide 
a potential answer, but this requires further investigation. 
 I observed that mutation of Sec8 causes a mild increase in nuclear volume. 
Given that the factors that govern nuclear volume are not well understood 
(Reviewed in Webster et al., 2009), it is difficult to speculate how Sec8 may be 
involved. The consensus in yeast seems to be that it is heavily influenced by both 
the cytoplasmic volume (Jorgensen et al., 2007; Neumann et al., 2007) and the 
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the cytoplasmic volume (Jorgensen et al., 2007; Neumann et al., 2007) and the 
stage of the cell cycle (Kume et al., 2017). Given that the sec8-1 mutant is blocked 
at septation, the increase in the N:C ratio may be an artefact of this, so would 
need to be investigated further (Kume et al., 2017). 
However, the nuclear import of proteins has also been implicated in controlling 
nuclear size (Newport et al., 1990; Brandt et al., 2006; D’Angelo et al., 2006; 
Dittmer et al., 2007; Kume et al., 2017). It is possible that Sec8 somehow 
regulates the transport of certain proteins through the nuclear pore, perhaps by 
influencing importins as discussed above. In its absence, certain factors may be 
over or under imported, resulting in the mild change in nuclear volume I observed.   
4.3. Novel Mitochondrial Roles for Sec8 
The only notable publication examining both the exocyst and mitochondria is a 
2014 study by Luo et al. who demonstrated that by fusing exocyst components 
with portions of mitochondrial outer membrane protein Tom20, the exocyst 
complex and vesicle trafficking could be ectopically targeted to the mitochondria. 
It demonstrated that ectopically-localised Sec3 could recruit the rest of the 
complex and reroute vesicular traffic to the mitochondria. This serves as a proof-
of-principle that exocyst members are still able to recruit their interactors, no 
matter their cellular location. If a subset of the exocyst is interacting with the 
mitochondrial envelope, then it is possible that it can target other proteins there 
too. The study points out that secretory vesicles cannot fuse with the 
mitochondria due to the lack of complementary tSNAREs. This, in addition to the 
fact that cytoplasmic transport of proteins to the mitochondria appears to be 
dependent on cytoplasmic chaperones such as Hsp70 (Young et al., 2003), and 
also the hydrophobicity and charge of the protein (Costello et al., 2017), makes it 
unlikely that the exocyst is involved in trafficking proteins to the mitochondria. 
That being said, chaperones like Hsp70 have been shown to localise at both the 
plasma membrane and in cytoplasmic vesicles (VanBuskirk et al., 1991; Singh et 
al., 1997), so whilst unlikely the possibility still exists.    
An obvious challenge to this putative association with mitochondria is that Sec8 
has never been demonstrated to localise to mitochondria. It may be that the 
subpopulation of Sec8 there is so small that the signal it is not detected by 
immunofluorescence, as it is so abundant in other cellular locations. Furthermore, 
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ectopic targeting of Sec3 to mitochondria in no way affected mitochondrial 
morphology (Luo et al., 2014), which challenges the clear phenotype I have 
observed upon disruption of Sec8. I cannot explain this discrepancy at present, 
especially as a further GFP-Trap performed in our lab using Sec3 detected even 
more mitochondrial interacting partners (unpublished lab data) and seems to 
support this association.  
An initial examination of mitochondrial morphology in the sec8-1 mutant showed 
that perturbation of Sec8 clearly affects mitochondrial morphology. The category 
with the highest frequency was ‘short looped’ mitochondria (37%), followed by 
‘short tubular’ mitochondria (24%). So how might mutation of Sec8 cause an 
increase in short mitochondria? The simplest explanation could be the health of 
the cells. As mentioned previously, the sec8-1 mutant exhibits a severe septation 
defect, even at lower temperatures. Mitochondria are very sensitive to the health 
of the cell, and it could be that the mitochondria are fragmented because these 
cells are very stressed and sick. That being said, unhappy cells tend to produce 
mitochondrial fragments rather than short tubules (unpublished lab observation). 
The sec8-1 cells survive for several days, and even when the septum is not 
broken down, the individual cell compartments still appear to progress normally 
through the cell cycle. Therefore, if the excess fragmentation is not due to cell 
stress, Sec8 is potentially influencing mitochondrial morphology itself, either 
directly or indirectly.   
The proteomics data was able to provide some clues in this respect. The results 
of the GFP-Trap indicate that whilst two out of three members of the mitochondrial 
fusion machinery are putative Sec8 interactors, none of the three members of the 
fission machinery are. This was supported by examination of mitochondrial 
dynamics, which showed that whilst the rate of fission was unaffected by mutation 
of Sec8, the rate of fusion was significantly reduced. This reduction in fusion could 
explain the increased proportion of cells with shorter mitochondria tubules and 
increased fragments. Mitochondria naturally fragment during mitosis, and then 
recover their longer morphology after cytokinesis (Jourdain et al., 2009). In the 
sec8-1 cells, with fission unaffected the mitochondria should still be able to 
fragment during mitosis, but with a reduced rate of fusion they may take longer 
to recover after cytokinesis. This could even be exacerbated by the previously 
described cytokinesis defect. 
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So Sec8 is somehow required for the efficient functioning of the mitochondrial 
fusion machinery. How might this interaction work? Mitochondrial fusion 
(Reviewed in Westermann, 2008) is thought to consist of four main steps, which 
have been better elucidated in S. cerevisiae.  Briefly, the two outer membranes 
of opposing mitochondria must first dock. The large outer-membrane GTPase 
Fzo1 (homolog of the mammalian mitofusins) plays a key role in forming trans-
complexes at this point. Next, lipid bilayer mixing occurs, merging the two 
membranes. Docking must then occur between the two inner membranes; the 
inner membrane GTPase Mgm1 (the orthologue of Msp1 in S. pombe and Opa1 
in mammalian cells) can form trans-complexes and has been shown to be 
required for this step. Again, lipid bilayer mixing must then occur, thus creating a 
single double-membrane bound mitochondria. Ugo1 binds to both Fzo1 and 
Mgm1, so is thought to coordinate both the interaction between these two 
proteins, and the fusion of the two membranes.  
Given the exocyst’s role in the fission/fusion of secretory vesicle and target 
membranes, it is possible that it may perform a similar function in helping these 
proteins to fuse mitochondrial membranes (Figure 16A). It is interesting that 
only Msp1 and Ugo1 were detected as double positive Sec8-interacting 
proteins, and not Fzo1. Fzo1 was detected as a true positive, but only in one 
replicate. However, as several other mitochondrial inner membrane proteins 
were also detected, for the sake of discussion I will entertain that the interaction 
with Ugo1 and Msp1 is more significant. It would appear more plausible that the 
exocyst could help to tether two adjacent mitochondria in sufficient proximity for 
Fzo1 complexes to occur. However given the proteomics, it seems that the 
exocyst could possibly help to tether the inner mitochondrial membranes 
instead in order to allow trans-complexes of Msp1 to form. Whilst it has been 
shown that Msp1 and Fzo1 can form trans-complexes and that they are key 
mediators of fusion, and that as GTPases they have the potential to generate 
the energy required, it has not yet been experimentally demonstrated that they 
can function as fusogens. Thus, the exocyst could be a plausible candidate for 
assisting in mitochondrial fusion by tethering membranes. It may also regulate 
Ugo1 similarly to how it mediates SNARE regulating proteins, as Ugo1 is 























Figure 16: Hypothetical models of Sec8's putative association with mitochondria
Potential mechanisms by which Sec8 may interact with mitochondria: (A) Tethering membranes or interacting with proteins during mitochondrial 
fusion (B) ER/Mitochondrial tethering (C) Indirectly influencing the levels of cytoplasmic chaperones by interacting with karyopherins (D) 







Another possibility is that Sec8 is somehow participating in the tethering between 
the ER and mitochondria (Figure 16B). This is one of the most extensively 
described organelle contact sites (Reviwed in Rowland et al., 2012) and is known 
to regulate mitochondrial distribution and dynamics. Clustering of the Sec8-
interacting partners by cellular compartment revealed that as well as 
mitochondrial envelope proteins, there was a cluster of ER proteins which was 
the third-most significant (Figure 8). The gap between the opposing membranes 
at ER/mitochondria contact sites is approximately 10-30nm (Csordás et al., 2006; 
Friedman et al., 2011), which is close enough to suppose that proteins on 
opposing membranes interact to form a tether (Rowland et al., 2012).Whilst an 
important role for such contact sites has been predominantly described for 
mitochondrial fission and distribution, an interplay with the mitochondrial fusion 
machinery has also been implicated. The mitofusins (mammalian orthologues of 
Fzo1) have been long thought to be involved in ER-mitochondria tethering 
(Kornmann, 2013; Raturi et al., 2013; Klecker et al., 2014; Prinz, 2014), but more 
recent studies indicate that they are actually antagonists of such tethering, as 
knockdown appears to promote an excessive and potentially harmful amount of 
tethering between the ER and mitochondria (Cosson et al., 2012; Filadi et al., 
2015). However, Fzo1 was a weak candidate as a Sec8-interacting partner, and 
no components of the ER-mitochondria tethering complex were detected. So it is 
possible that the exocyst is not interacting directly, instead serving a separate 
function. Perhaps it tethers the membranes in close enough proximity for 
complexes to form at contact sites?  Perhaps it stabilises Ugo1 and/or Msp1’s 
associations with Fzo1 to maintain the integrity of inner/outer membrane contact 
sites? 
The inefficiency of the Mitotracker stain on these cells is also worth noting, as this 
indicates that the mitochondria may also have a functional defect. Perhaps Sec8 
may be responsible for the delivery of other mitochondrial components, and that 
its absence therefore affects processes beyond just fusion. Whilst it was not 
possible to examine mitochondrial function within the time constraints of this 
study, it leaves exciting potential for further work.  
It is intriguing to speculate as to whether this putative association is conserved in 
mammalian cells. As discussed in Section 1.1.3, Sec8 can influence the 
expression levels of Pirh2 (an E3 ubiquitin ligase) which in turn affects the 
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organisation of intermediate filament protein cytokeratin 8 (Tanaka et al., 2015). 
Disruption of the interaction between Pirh2 and cytokeratin 8 leads to the 
aggregation of cytokeratin 8 filaments and mitochondrial redistribution, likely by 
affecting a microtubule-dependent process (Duan et al., 2009). It has therefore 
been previously speculated (Tanaka et al., 2015) that regulation of the Pirh2-
Cytokeratin 8 interaction by Sec8 could potentially influence the distribution of 
mitochondria. This would be an intriguing possibility to test in future.  
4.4. Links Between the Exocyst, the Nucleus and 
Mitochondria? 
One of the karyopherins detected in the GFP-Trap - Mtr10 - is an importin β-like 
protein, whose function has not been characterised in S. pombe. However in S. 
cerevisiae it has been shown to be required for nucleocytoplasmic transport of 
Npl3. Npl3 is a chaperone essential for mRNA export, that has also been shown 
to be responsible for mitochondrial protein targeting (Ellis et al., 1993). Mutation 
of Npl3 increased its residency in the cytoplasm, increased localisation to 
polysomes (clusters of cytoplasmic ribosomes translating an mRNA), and 
stabilised multiple cytoplasmic mRNAs, including those encoding mitochondrial 
precursor proteins (Gratzer et al., 2000). Overexpression of other karyopherins 
known to transport Npl3 suppresses defects in mitochondrial protein import 
(Belgareh et al., 1999). It was therefore suggested that Npl3 may indirectly 
influence co-translational protein import into mitochondria. As discussed 
previously, the mechanism by which Sec8 is able to influence protein expression 
in multiple cellular contexts is not well understood. If it is interacting with 
karyopherins, and subsequently somehow affecting the levels of cytoplasmic 
chaperones (Figure 16C), then this could be affecting mRNA levels and 
subsequent protein expression of mitochondrial proteins (and many others). Npl3 
shows 32% coverage with mRNA export factor Srp2 in S. pombe, so it would be 
interesting to investigate whether the expression or cytoplasmic residency time 
of Srp2 (or even other mRNA chaperones) is affected in the sec8-1 mutant. 
Another interesting result from the proteomics was the detection of Css1 as a 
putative Sec8-interacting partner. It had the highest scores of all the mitochondrial 
proteins detected.  This enzyme is the ortholog of Isc1, the S. cerevisiae inositol 
sphingolipid phospholipase C. Sphingolipids are both key structural components 
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of the plasma membrane and essential signalling molecules. Isc1 catalyses the 
hydrolysis of complex sphingolipids to produce ceramide: the enzyme at the 
centre of the sphingolipid pathway. Ceramide can influence several different 
processes including apoptosis, cell cycle progression, DNA damage response 
and differentiation (Reviewed in Tripathi et al., 2015). Isc1 sits in the 
mitochondrial outer membrane in the post-diauxic phase (De Avalos et al., 2004; 
Kitagaki et al., 2007), and as well as an involvement in apoptosis (Almeida et al., 
2008) it has also interestingly been shown to somehow regulate nuclear gene 
expression (Kitagaki et al., 2009). When S. cerevisiae encounters low levels of 
environmental glucose, extensive metabolic adaptation and changes in gene 
expression occur, which is known as the ‘diauxic shift’.  Many genes whose 
expression is induced during diauxic shift are not induced in Isc1-deficient cells 
(Kitagaki et al., 2009). The authors speculate that Isc1 may function in signalling 
the health of the mitochondria to the rest of the cell, and thus affect the import of 
respiratory substrates into mitochondria. However the mechanism by which this 
is achieved is not fully clear, and how Sec8 may be involved is interesting to 
speculate. Sec8 is already known to be involved in several signalling pathways, 















GFP-Trap has proved an extremely useful technique in providing hints at novel 
cellular interactions. I have unearthed putative associations between Sec8 and 
the nuclear envelope, the mitochondrial envelope and the mitochondrial fusion 
machinery, none of which have been previously described.  
I have shown that Sec8 appears to be involved in regulating mitochondrial 
morphology, likely through mitochondrial fusion. In order to further elucidate the 
nature of Sec8’s interaction with mitochondria, there are several important 
questions that will need to be answered. The putative Sec8-interacting partners 
need to be validated by a technique such as reciprocal co-immunoprecipitation, 
yeast two hybrid, or by a study of genetic interactions. This would help confirm 
whether Sec8 does indeed bind to these proteins. If so, then the next question 
that would need to be answered - does Sec8 localise to the mitochondrial 
envelope? If so, then is it on the outer membrane or in the intermembrane space? 
How does it get there? If it does not localise to mitochondria, then where is it 
interacting with these proteins? The fact that two GFP-Traps performed in our lab 
(one on Sec8 and one on Sec3) both detected mitochondrial interacting proteins 
suggests that either this mitochondrial association is not Sec8 specific, or that 
this is an artefact of the method i.e. incomplete permeabilisation resulted in the 
pulling down of the entire mitochondrial envelope. However, given that thee 
functional analyses seem to confirm an involvement with mitochondria, the latter 
seems less likely.  In addition, it would be interesting to see if this involvement 
with mitochondria is conserved in mammalian cells. Unpublished preliminary data 
I have collected (not shown) does appear to support this. This potentially links in 
with one of Sec8’s already described roles in regulating the Pirh2/cytokeratin 8 
interaction. Furthermore, abnormal mitochondrial morphology has been 
described in several human diseases (Trimmer et al., 2000; Chen et al., 2009), 
which highlights the need to better characterise Sec8’s (or most likely the 
exocyst’s) involvement.  
Functional experiments also demonstrated that mutation of Sec8 mildly affects 
nuclear volume. As that the mechanisms which regulate nuclear volume are still 
not fully understood, it will require extensive further investigation to determine 
how Sec8 is involved. However, given that some existing evidence seems to 
77 
 
suggest that Sec8 may be able to regulate protein expression, it is perhaps worth 









Wild-type IJ1209 972 h- Lab stock 
Wild-type IJ137 ade6-M216 leu1-32 ura4-D18 h- Lab stock 
sec8-1 IJ846 sec8-1 leu1-32 ura4-D18 h+ 
Balasubramanian Lab[a] 
(Wang et al., 2002) 
sec8-1 IJ881 sec8-1 ade6-M216 leu1-32 ura4-D18 h+ Lab Stock 
sec8-gfp IJ869 sec8-gfp-ura4 leu1-32 h- 
Balasubramanian Lab[a] 
(Wang et al., 2002) 
pom152-gfp IJ489 pom152-gfp-kanMX6 leu1-32 ura4-D18 h- Toda Lab[b] 
sec8-1 pom152-gfp IJ1555 sec8-1 pom152-gfp-kanMX6  leu1-32 ura4-D18 This study 
coxIV-dsrfp IJ426 ade6-M210 leu1-32::nmt1::coxIVdsrfp:leu1+ ura4-D18 h- 
Yaffe Lab[c]  
(Chiron et al., 2008) 
sec8-1 coxIV-dsrfp IJ1553 sec8-1 leu1-32::nmt1::coxIVdsrfp:leu1+  This study 
 
[a] - The Cancer Research UK Cambridge Institute, UK.   
[b] - Hiroshima University, Japan. 




Appendix Table 2: Recipe for rich medium (YE5S). Solution was made up in water, and the pH adjusted 
to 5.6 using HCL. 
Appendix Table 3: Recipe for mating medium (ME4S). Solution was prepared in water, and the pH 
adjusted to 7.6 using HCL. 
Ingredient Manufacturer Concentration 
Difco Malt Extract Oxoid 30 g/L 
Histidine Sigma Aldrich 75 mg/L 
Adenine Sigma Aldrich 75 mg/L 
Uracil Sigma Aldrich 75 mg/L 
Leucine Sigma Aldrich 75 mg/L 
 
 
Appendix Table 4: Recipe for freezing medium (YFM). Solution was prepared in water. 
Ingredient Manufacturer Concentration 
Yeast Extract VWR Chemicals 10 g/L 
Bacto tryptone BD Biosciences 10 g/L 
Glucose Fisher Scientific 20 g/L 
Glycerol Fisher Scientific 25%  
 
 
Appendix Table 5: Recipe for minimal medium (EMM) supplemented with amino acids. Solution was 
prepared in water, and the pH adjusted to 5.6 using HCL. 
Ingredient Manufacturer Concentration 
Potassium hydrogen phtalate Sigma Aldrich 3 g/L 
Na2HPO4 Alfa Aesar 2.2 g/L 
NH4Cl Fisher Scientific 5 g/L 
Adenine Sigma Aldrich 250 mg/L 
Uracil Sigma Aldrich 250 mg/L 
Leucine Sigma Aldrich 250 mg/L 
Glucose  5%  
Salts Solution 
      MgCl2 6H2O             
      CaCl2 2H2O 
      KCl 
      Na2SO4 
 
5.2   mM                                  









      Pantothemic Acid      
      Nicotinic Acid 
      Myo-inositol 
      Biotin 100X 
  









Minerals Solution  
      Boric acid 
      MnSO4 
      ZnSO4 7H2O 
      FeCl2 6H2O 
      Molybdic acid 
      KI 
      CuSO4 5H2O 
      Citric acid 
 




















Ingredient Manufacturer Concentration 
Yeast Extract VWR Chemicals 5 g/L 
Glucose Fisher Scientific 30 g/L 
Uracil Sigma Aldrich 250 mg/L 
Adenine Sigma Aldrich 250 mg/L 
Histidine Sigma Aldrich 250 mg/L 
Lysine Sigma Aldrich 250 mg/L 
Leucine Sigma Aldrich 250 mg/L 
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Appendix Table 6: Recipe for Extraction Buffer (EB). Solution was prepared in water, used at 4°C and 
stored at 20°C. 
Ingredient Manufacturer Concentration 
EGTA Sigma Aldrich 5mM 
Ethylenediaminetetraacetic acid (EDTA) Sigma Aldrich 5mM 
HEPES Sigma Aldrich 50mM 
NaF Sigma Aldrich 50mM 
Na-β-glycerophosphate Sigma Aldrich 50mM 
Phenylmethylsulphonyl fluoride (PMSF) Sigma Aldrich 1mM 
Protease Inhibitor Cocktail Sigma Aldrich 1x 
Triton X100 Sigma Aldrich 0.2% 
 
Appendix Table 7: Recipe for 10% Polyacrylamide Running Gel. Solution was prepared in water. 
Ingredient Manufacturer Concentration 
Tris-HCl (pH=8.8) Sigma 0.375 mM 
SDS  Sigma 0.0002% 
Protogel Runing Gel  National diagnostics 0.0801% 
APS  Sigma 0.0005% 
TEMED Sigma 0.001% 
 
 
























O74562 sec8 Exocyst complex component sec8 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sec8 PE=1 SV=2 - [SEC8_SCHPO]11.58 790.59 85 779.01 68.27 0.00 435.43 63 435.43
O74846 sec6 Exocyst complex component sec6 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sec6 PE=1 SV=2 - [SEC6_SCHPO]2.86 280.85 33 278.00 98.22 0.00 146.99 26 146.99
O75006 sec15 Exocyst complex component sec15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sec15 PE=3 SV=2 - [SEC15_SCHPO]0.00 259.09 35 259.09 0.00 102.12 26 102.12
O13705 sec10 Exocyst complex component sec10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sec10 PE=1 SV=2 - [SEC10_SCHPO]0.00 255.99 51 255.99 0.00 104.84 33 104.84
O94598 sec5 Exocyst complex component sec5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sec5 PE=1 SV=1 - [SEC5_SCHPO]1.84 170.08 32 168.24 92.52 0.00 71.32 24 71.32
O14226 exo84 Exocyst complex component exo84 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=exo84 PE=3 SV=2 - [EXO84_SCHPO]0.00 168.42 26 168.42 0.00 60.52 16 60.52
Q10339 exo70 Exocyst complex component exo70 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=exo70 PE=1 SV=1 - [EXO70_SCHPO]0.00 130.21 28 130.21 0.00 41.36 14 41.36
Q10411 spo15 Sporulation-specific protein 15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=spo15 PE=1 SV=1 - [SPO15_SCHPO]29.98 103.30 33 73.32 3.45 17.55 47.89 13 30.34 2.73
O14065 tcb1 Tricalbin, C2 domain protein (phospholipid binding) ER-plasma membrane tethering protein Tcb1 (predicted) 33.58 91.05 22 57.47 2.71 14.36 55.55 18 41.19 3.87
Q10324 sec3 Uncharacterized protein C17G8.12 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC17G8.12 PE=4 SV=1 - [YD6C_SCHPO]0.00 100.29 25 100.29 0.00 29.17 11 29.17
Q9UUE2 csx2; cnt5 Protein csx2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=csx2 PE=1 SV=1 - [CSX2_SCHPO] 6.80 32.78 11 25.98 4.82 13.11 35.84 9 22.72 2.73
Q1MTR3 vid27 Vacuolar import and degradation protein 27 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=vid27 PE=1 SV=1 - [VID27_SCHPO]11.81 35.55 10 23.74 3.01 6.80 22.02 6 15.22 3.24
O14072 cta4 Manganese-transporting ATPase 4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cta4 PE=3 SV=1 - [ATC4_SCHPO]14.08 35.80 12 21.72 2.54 7.46 20.64 9 13.18 2.77
Q09891 Unassigned Putative phospholipid-transporting ATPase C24B11.12c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC24B11.12c PE=3 SV=1 - [ATCX_SCHPO]8.09 36.65 13 28.57 4.53 0.00 13.06 5 13.06
Q09857 uso1 Intracellular protein transport protein uso1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=uso1 PE=3 SV=3 - [USO1_SCHPO]8.04 35.30 13 27.26 4.39 2.43 13.69 7 11.25 5.62
O74319 taf73 Transcription initiation factor TFIID subunit taf73 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=taf73 PE=1 SV=1 - [TAF73_SCHPO]8.36 23.66 8 15.30 2.83 5.50 22.98 9 17.47 4.18
O13791 slt1 Protein slt1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=slt1 PE=1 SV=3 - [SLT1_SCHPO] 4.67 33.62 9 28.95 7.20 1.77 12.18 5 10.41 6.90
Q9UT35 gdp1 Guanosine-diphosphatase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gdp1 PE=3 SV=1 - [GDA1_SCHPO] 9.40 25.71 8 16.31 2.73 6.65 17.13 7 10.48 2.58
O74369 css1 Inositol phosphosphingolipids phospholipase C OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=css1 PE=1 SV=2 - [CSS1_SCHPO]7.14 24.89 11 17.75 3.49 1.92 17.47 9 15.55 9.08
Q10064 tra2 NuA4 complex phosphatidylinositol pseudokinase complex subunit Tra2 3.36 35.29 16 31.92 10.49 0.00 6.65 9 6.65
O14283 prr1 Transcription factor prr1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=prr1 PE=1 SV=2 - [PRR1_SCHPO] 10.87 27.96 8 17.09 2.57 2.41 13.57 5 11.16 5.63
P78847 nup186 Nucleoporin nup186 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nup186 PE=2 SV=2 - [NU186_SCHPO] 6.77 18.81 9 12.03 2.78 5.96 20.45 7 14.49 3.43
O14290 Unassigned Unassigned BCAP family homolog C9E9.04 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC9E9.04 PE=4 SV=1 - [YF14_SCHPO]5.35 14.19 5 8.84 2.65 8.80 23.85 6 15.04 2.71
O74349 rkr1 E3 ubiquitin-protein ligase listerin OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rkr1 PE=3 SV=1 - [LTN1_SCHPO]6.22 22.84 8 16.62 3.67 0.00 14.43 6 14.43
Q10435 Unassigned Unassigned hect-type ubiquitin-protein ligase E3 C12B10.01c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC12B10.01c PE=3 SV=2 - [YDE1_SCHPO]6.35 25.57 12 19.21 4.02 3.03 7.85 5 4.83 2.60
Q7Z9H9 fig4 Polyphosphoinositide phosphatase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC1093.03 PE=3 SV=3 - [FIG4_SCHPO]0.00 22.52 8 22.52 0.00 10.46 3 10.46
O42901 orm1 ORMDL family protein Orm1 (predicted) 3.81 17.91 4 14.10 4.70 3.01 13.16 4 10.15 4.37
Q10243 vps26 Vacuolar protein sorting-associated protein 26 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=vps26 PE=3 SV=1 - [VPS26_SCHPO]2.96 14.95 2 11.99 5.06 0.00 15.95 4 15.95
O13282 taf5 Transcription initiation factor TFIID subunit 5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=taf5 PE=1 SV=1 - [TAF5_SCHPO]7.65 22.31 6 14.67 2.92 0.00 7.87 4 7.87
Q10496 gyp51 GTPase activating protein Gyp51 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gyp51 PE=3 SV=1 - [GYP51_SCHPO]2.08 27.37 10 25.29 13.17 0.00 2.67 2 2.67
O14197 Unassigned Uncharacterized auxin family transmembrane transporter (predicted) C5D6.04 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC5D6.04 PE=3 SV=1 - [YDQ4_SCHPO]6.65 18.47 3 11.82 2.78 3.66 10.17 2 6.50 2.77
Q9P782 aha1 Chaperone activator Aha1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC1711.08 PE=2 SV=1 - [YNY8_SCHPO]5.01 18.32 10 13.31 3.65 2.17 10.17 9 8.00 4.69
O74534 sly1 Protein sly1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sly1 PE=3 SV=1 - [SLY1_SCHPO] 5.73 18.27 8 12.54 3.19 0.00 9.22 6 9.22
O60081 trm72 tRNA 2'-O-methylase subunit Trm72 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1494.07 PE=3 SV=1 - [YQK7_SCHPO]4.25 13.37 7 9.12 3.15 3.40 13.17 6 9.77 3.87
P50524 rpn12 26S proteasome regulatory subunit rpn12 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rpn12 PE=1 SV=1 - [RPN12_SCHPO]7.46 20.41 6 12.95 2.74 1.72 5.47 4 3.75 3.18
Q9P7W8 rsc9 Chromatin structure-remodeling complex subunit rsc9 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rsc9 PE=1 SV=1 - [RSC9_SCHPO]6.42 21.62 6 15.20 3.37 0.00 4.21 3 4.21
Q9Y7K2 tor2 Serine/threonine-protein kinase tor2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tor2 PE=1 SV=2 - [TOR2_SCHPO]2.79 16.58 11 13.79 5.93 0.00 8.57 5 8.57
O14301 aip1 Actin cortical patch component Aip1 C9G1.05 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC9G1.05 PE=3 SV=1 - [YE85_SCHPO]1.96 4.94 2 2.98 2.52 0.00 19.60 5 19.60
O74925 pep3 Vacuolar membrane protein pep3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pep3 PE=3 SV=1 - [PEP3_SCHPO]4.65 15.42 7 10.77 3.31 0.00 8.53 5 8.53
Q9UTH0 nup132 Nucleoporin nup132 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nup132 PE=1 SV=1 - [NU132_SCHPO] 1.90 21.17 3 19.27 11.12 0.00 2.35 2 2.35
O42954 mbx1 MADS-box transcription factor 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mbx1 PE=1 SV=2 - [MBX1_SCHPO]2.97 14.76 3 11.79 4.97 0.00 8.18 4 8.18
Q9Y7J8 psy2 Protein phosphatase PP4 complex subunit Psy2  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC216.01c PE=2 SV=3 - [YGL1_SCHPO]2.11 16.01 7 13.91 7.61 0.00 6.38 4 6.38
Q9P7X5 ppk32 Protein kinase domain-containing protein ppk32 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk32 PE=1 SV=1 - [PPK32_SCHPO]0.00 13.62 4 13.62 0.00 8.74 3 8.74
O14340 Unassigned Sterol binding ankyrin repeat protein (predicted)  C2F12.05c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC2F12.05c PE=1 SV=2 - [YB35_SCHPO]3.10 9.03 1 .94 2.92 0.00 13.03 3 13.03
O94374 imp1 Importin subunit alpha-2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=imp1 PE=1 SV=1 - [IMA2_SCHPO] 5.13 16.62 5 11.49 3.24 0.00 5.12 2 5.12
Q9UTK7 dsc2 DSC E3 ubiquitin ligase complex subunit 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=dsc2 PE=1 SV=1 - [DSC2_SCHPO]0.00 12.90 2 12.90 0.00 8.34 2 8.34
Q9UUH0 Unassigned Mannose-ethanolamine phosphate phosphodiesterase (predicted) C630.12 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC630.12 PE=3 SV=1 - [YKIC_SCHPO]3.17 15.03 6 11.85 4.74 0.00 6.15 1 6.15
Q10331 nup107 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nup107 PE=1 SV=4 - [NU107_SCHPO] 5.40 19.10 8 13.70 3.54 0.00 1.67 1 1.67
O94712 gid1; vid30 GID complex subunit, Ran GTPase binding protein Gid1  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1259.12c PE=3 SV=2 - [YC5C_SCHPO]1.74 12.24 5 10.50 7.02 0.00 7.60 3 7.60
O13897 fsh2 Serine hydrolase-like OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC22A12.06c PE=3 SV=1 - [YF36_SCHPO]4.58 11.49 3 6.90 2.51 0.00 7.96 3 7.96
Q09849 arp42 SWI/SNF and RSC complexes subunit arp42 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=arp42 PE=1 SV=2 - [ARP42_SCHPO]0.00 8.55 3 8.55 2.92 10.60 3 7.68 3.63
Q9P7R8 gea1 Guanyl-nucleotide exchange factor  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC211.03c PE=1 SV=1 - [YHV3_SCHPO]0.00 14.71 7 14.71 0.00 3.84 2 3.84
O74773 msh2 DNA mismatch repair protein msh2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=msh2 PE=3 SV=2 - [MSH2_SCHPO]4.40 14.22 6 9.81 3.23 0.00 4.09 3 4.09
Q10429 cnd3 Condensin complex subunit 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cnd3 PE=1 SV=1 - [CND3_SCHPO]3.86 13.03 5 9.17 3.38 0.00 4.98 2 4.98
Q09779 tho2 THO complex subunit 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tho2 PE=1 SV=3 - [THO2_SCHPO] 5.00 15.64 7 10.64 3.13 0.00 2.16 3 2.16
Q9C100 ogm2 Dolichyl-phosphate-mannose--protein mannosyltransferase 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ogm2 PE=3 SV=1 - [PMT2_SCHPO]2.19 12.32 4 10.13 5.63 0.00 5.30 5 5.30
Q10108 edc1 Dcp2-Dcp1 mRNA-decapping complex subunit Edc1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC18G6.09c PE=1 SV=1 - [YAQ9_SCHPO]2.13 5.85 2 3.72 2.75 0.00 11.34 2 11.34
P78953 mid1 Division mal foutue 1 protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mid1 PE=1 SV=1 - [MID1_SCHPO] 0.00 12.93 4 12.93 0.00 4.10 1 4.10
O74504 Unassigned DUF1769 famil protein C594.01 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC594.01 PE=1 SV=2 - [YJD1_SCHPO]3.22 13.52 4 10.30 4.20 0.00 3.21 2 3.21
O13636 tim50 Mitochondrial import inner membrane translocase subunit tim50 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tim50 PE=3 SV=1 - [TIM50_SCHPO]0. 0 8.94 3 8.94 0.00 7.31 1 7.31
Q09743 ste20 Target of rapamycin complex 2 subunit ste20 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ste20 PE=1 SV=1 - [RICTR_SCHPO]0.00 12.27 2 12.27 0.00 3.91 2 3.91
Q9P7W0 Unassigned Optic atrophy 3 family protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC1703.11 PE=3 SV=1 - [OPA3_SCHPO]3.88 12.41 1 8.54 3.20 0.00 3.53 1 3.53
Q10165 cnt6 Probable ribosylation factor GTPase-activating protein cnt6 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cnt6 PE=1 SV=1 - [CNT6_SCHPO]0.00 8.47 4 8.47 0.00 7.21 2 7.21
Q10268 mac1 Membrane-anchored protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mac1 PE=1 SV=1 - [MAC1_SCHPO]3.28 12.24 2 8.97 3.73 0.00 3.35 1 3.35
P00046 cyc1 Cytochrome c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cyc1 PE=1 SV=3 - [CYC_SCHPO] 0.00 2.07 1 2.07 2.13 13.49 4 11.36 6.33
O14188 rng2 Ras GTPase-activating-like protein rng2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rng2 PE=1 SV=1 - [RNG2_SCHPO]1.79 6.46 6 4.67 3.61 0.00 8.83 6 8.83
O59712 Unassigned  Sodium ion transmembrane transporter (predicted) C3B8.04c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC3B8.04c PE=3 SV=1 - [YBH4_SCHPO]0.00 8.38 4 8.38 0.00 6.72 3 6.72
Q09682 pre9 Probable proteasome subunit alpha type-3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC13C5.01c PE=3 SV=1 - [PSA3_SCHPO]2.20 8.4 2 6.22 3.82 1.97 6.23 2 4.26 3.16
Q9USJ4 nte1 Lysophospholipase NTE1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nte1 PE=3 SV=1 - [NTE1_SCHPO] 0.00 12.55 6 12.55 0.00 1.90 1 1.90
Q9USZ2 mtr10 Karyopherin, nuclear import receptor Mtr10  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC11G11.07 PE=3 SV=2 - [YNR7_SCHPO]0.00 10.57 6 10.57 0.00 2.81 2 2.81
O42963 nup44 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nup44 PE=2 SV=1 - [NUP44_SCHPO] 2.23 10.56 4 8.33 4.74 0.00 2.65 2 2.65
P33277 gap1 GTPase-activating protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gap1 PE=3 SV=1 - [GAP1_SCHPO] 3.96 10.35 5 6.39 2.62 0.00 2.75 2 2.75
O42854 bbc1 SH3 domain-containing protein C23A1.17 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC23A1.17 PE=1 SV=1 - [YFHH_SCHPO]0.00 6.55 3 6.55 2.34 6.51 3 4.17 2.78
Q9P792 nbr1 Cargo receptor for selective autophagy pathway OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBP35G2.11c PE=3 SV=1 - [YN8B_SCHPO]2.68 11.20 4 8.52 4.18 0.00 1.65 1 1.65
Q9P7H8 ecm29 Proteasome component ecm29 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ecm29 PE=1 SV=1 - [ECM29_SCHPO]2.38 8.97 8 6.60 3.77 0.00 3.51 6 3.51
Q10222 pta1 mRNA cleavage and polyadenylation specificity factor complex subunit pta1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pta1 PE=1 SV=2 - [PTA1_SCHPO]1.73 7.96 4 6.24 4.61 0.00 4.26 3 4.26
O42998 sip1 Pof6 interactor protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sip1 PE=1 SV=1 - [SIP1_SCHPO] 0.00 6.00 5 6.00 2.11 6.10 3 4.00 2.90
Q1MTQ5 mug89 Meiotically up-regulated gene 89 protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mug89 PE=1 SV=1 - [MUG89_SCHPO]0.00 8.82 4 8.82 0.00 2.31 1 2.31
O94548 Unassigned Conserved fungal proteins OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1322.09 PE=3 SV=1 - [MTC1_SCHPO]0.00 7.79 3 7.79 0.00 3.12 2 3.12
Q1MTN8 Unassigned Conserved fungal protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC16D10.01c PE=3 SV=2 - [ACL4_SCHPO]1.60 5.81 2 4.21 3.63 0.00 5.07 2 5.07
Q9UTF8 ugo1 Mitochondrial fusion and transport protein ugo1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ugo1 PE=3 SV=1 - [UGO1_SCHPO]0.00 8.08 3 8.08 0.00 2.56 1 2.56
O74738 set10 Ribosomal lysine N-methyltransferase set10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=set10 PE=3 SV=1 - [SET10_SCHPO]0.00 8.79 3 8.79 0.00 1.84 1 1.84
O74547 bit61 Target of rapamycin complex 2 subunit bit61 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=bit61 PE=1 SV=1 - [BIT61_SCHPO]0.00 6.90 2 6.90 0.00 3.47 1 3.47
O74541 Unassigned Uncharacterized transcriptional regulatory protein C777.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC777.02 PE=3 SV=4 - [YCV2_SCHPO]0.0 7.86 1 7.86 0.00 2.45 1 2.45
O14130 Unassigned Uncharacterized transcriptional regulatory protein C3C7.04 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC3C7.04 PE=3 SV=1 - [YF54_SCHPO]1.95 7. 7 3 5.42 3.78 0.00 2.74 2 2.74
Q9P382 nup82 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nup82 PE=3 SV=1 - [NUP82_SCHPO] 0.00 8.12 4 8.12 0.00 1.70 2 1.70
Q9UT67 imt1 Inositol phosphoceramide mannosyltransferase 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC4F11.04c PE=3 SV=1 - [IMT2_SCHPO]0.00 5.89 2 5.89 0.00 3.58 1 3.58
Q9UQX0 sod2 Superoxide dismutase [Mn], mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sod2 PE=1 SV=1 - [SODM_SCHPO]0.00 2.49 2 2.49 2.39 6.64 4 4.24 2.78
P87114 fft1 ATP-dependent helicase fft1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=fft1 PE=3 SV=1 - [FFT1_SCHPO] 0.00 7.30 4 7.30 0.00 1.73 2 1.73
O42930 vps10 Vacuolar protein sorting/targeting protein 10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=vps10 PE=1 SV=1 - [VPS10_SCHPO]2.17 6.21 2 4.04 2.87 0.00 2.73 2 2.73
O74481 pdi5 Protein disulfide isomerase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1840.08c PE=3 SV=1 - [YQJ8_SCHPO]2.04 6.27 4 4.23 3.07 0.00 2.27 1 2.27
O94516 pex16 Peroxisomal membrane protein PEX16 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pex16 PE=1 SV=2 - [PEX16_SCHPO]0.00 6.07 2 6.07 0.00 2.32 1 2.32
O94520 emc4 ER membrane protein complex subunit 4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1281.03c PE=3 SV=1 - [YQ13_SCHPO]1.62 4.34 2 2.71 2.67 0.00 4.01 1 4.01
P78871 rst2 Zinc finger protein rst2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rst2 PE=2 SV=2 - [RST2_SCHPO] 1.99 5.41 1 3.42 2.72 0.00 2.50 2 2.50
O14068 Unassigned Conserved fungal protein C1687.07 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC1687.07 PE=3 SV=1 - [YFF7_SCHPO]0.00 4.54 2 4.54 0.00 3.14 1 3.14
Q9P7J5 yta4 Mitochondrial outer membrane ATPase Msp1/Yta4  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC24B10.10c PE=3 SV=1 - [YJNA_SCHPO].00 4.81 2 4.81 0.00 2.72 1 2.72
Q9UTL2 klp8 Kinesin-like protein 8 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=klp8 PE=1 SV=1 - [KLP8_SCHPO] 0.00 4.95 2 4.95 0.00 2.57 2 2.57
Q10361 etp1 Electron transfer protein 1, mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=etp1 PE=1 SV=2 - [ETP1_SCHPO]0.00 5.39 2 5.39 0.00 2.09 2 2.09
O59747 pdf1 Palmitoyl-protein thioesterase-dolichyl pyrophosphate phosphatase fusion 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pdf1 PE=1 SV=2 - [PDF1_SCHPO]0.00 2.54 1 2.54 0.00 4.74 1 4.74
Q8WZK2 its8 GPI ethanolamine phosphate transferase 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=its8 PE=1 SV=1 - [MCD4_SCHPO]0.00 4.70 3 4.70 0.00 2.05 1 2.05
Q9UTK6 Unassigned RNA-binding splicing factor (predicted) C1486.03 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC1486.03c PE=3 SV=1 - [YKR3_SCHPO]0.00 3.77 2 3.77 0.00 2.57 1 2.57
O94689 yme2 Mitochondrial escape protein 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=yme2 PE=3 SV=1 - [YME2_SCHPO]0.00 4.05 3 4.05 0.00 2.20 1 2.20
Q9Y7N9 Unassigned PXA domain-containing protein C1450.12 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1450.12 PE=1 SV=1 - [YCKC_SCHPO]0.00 2.92 1 2.92 0.00 3.15 1 3.15
Q9UUI8 pet1 Phosphoenolpyruvate transmembrane transporter Pet1OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC22F8.04 PE=3 SV=1 - [YIY4_SCHPO]0.00 4.21 2 4.21 0.00 1.74 2 1.74
P27584 gpa1 Guanine nucleotide-binding protein alpha-1 subunit OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gpa1 PE=3 SV=4 - [GPA1_SCHPO]0.00 3.70 1 3.70 0.00 2.21 1 2.21
Q09922 Unassigned Transcription factor, zf-fungal binuclear cluster type  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC1F7.11c PE=3 SV=1 - [YAKB_SCHPO]0.00 3.43 2 3.43 0.00 2.30 3 2.30
Q09787 Unassigned SSU-rRNA maturation protein Tsr4 homolog 2  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC13G6.09 PE=4 SV=1 - [YA99_SCHPO]0.00 2.39 1 2.39 0.00 3.34 1 3.34
O42929 tma22 Translation machinery-associated protein 22 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tma22 PE=3 SV=1 - [DENR_SCHPO]0.00 3.32 3 3.32 0.00 2.35 1 2.35
O94691 jmj3 Lid2 complex component jmj3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=jmj3 PE=3 SV=1 - [JMJ3_SCHPO] 0.00 3.81 2 3.81 0.00 1.76 1 1.76
Q10347 any2 Arrestin-related endocytic adaptor Any2  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC1F12.05 PE=4 SV=1 - [YDA5_SCHPO]0.00 3.53 2 3.53 0.00 1.88 1 1.88
Q09830 Unassigned GTPase activating protein (predicted) C4G8.04 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC4G8.04 PE=1 SV=1 - [YAD4_SCHPO]0.00 3.51 4 3.51 0.00 1.79 2 1.79
O42973 Unassigned Conserved eukaryotic protein, human IFRD1 ortholog C20F10.03 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC20F10.03 PE=1 SV=1 - [YGZ3_SCHPO]0.00 2.52 2 2.52 0.00 2.60 1 2.60
Q1MTQ1 tea2 Kinesin-like protein tea2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tea2 PE=1 SV=1 - [TEA2_SCHPO] 0.00 2.57 3 2.57 0.00 2.53 1 2.53
O74308 gsf1 Transcription factor, zf-fungal binuclear cluster type Gsf1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC15D4.02 PE=3 SV=3 - [YOG2_SCHPO]0.0 2.15 1 2.15 0.00 2.91 1 2.91
Q9US60 klp3 Kinesin-like protein 3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=klp3 PE=2 SV=1 - [KLP3_SCHPO] 0.00 2.60 2 2.60 0.00 2.41 1 2.41
O14002 mak2 Peroxide stress-activated histidine kinase mak2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mak2 PE=3 SV=1 - [MAK2_SCHPO]0.00 3.31 1 3.31 0.00 1.60 2 1.60
Q9UTK4 nup189 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=nup189 PE=1 SV=1 - [NU189_SCHPO] 0.00 2.83 2 2.83 0.00 1.85 2 1.85
Q10245 ifa38 Ketoreductase involved in fatty acid elongation  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC4G9.15 PE=3 SV=1 - [MKAR_SCHPO]0.00 2.99 2 2.99 0.00 1.69 1 1.69
Q92359 puf4 Pumilio family RNA-binding protein Puf4  OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC6G9.14 PE=3 SV=1 - [YDHE_SCHPO]0.00 2.13 1 2.13 0.00 2.54 1 2.54
Q9UT38 vps16 Probable vacuolar protein sorting-associated protein 16 homolog OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=vps16 PE=3 SV=1 - [VPS16_SCHPO]0.00 2.35 1 2.35 0.00 2.28 1 2.28
Q9UTN3 cid14 Poly(A) RNA polymerase cid14 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cid14 PE=1 SV=2 - [CID14_SCHPO]0.00 1.69 1 1.69 0.00 2.91 1 2.91
O74823 red5 Zinc finger CCCH domain-containing protein C337.12 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC337.12 PE=3 SV=3 - [YBJC_SCHPO]0.00 2.27 2 2.27 0.00 2.34 1 2.34
P78875 tpp1 Trehalose-phosphatase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=tpp1 PE=1 SV=2 - [TPP1_SCHPO] 0.00 2.37 2 2.37 0.00 2.08 3 2.08
O43092 oxa102 Mitochondrial inner membrane protein oxa1-2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=oxa102 PE=2 SV=2 - [OXA12_SCHPO]0.00 2.03 1 2.03 0.00 2.32 1 2.32
Q10093 Unassigned 5-oxoprolinase (ATP-hydrolizing) OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPAC11D3.14c PE=3 SV=1 - [YAOE_SCHPO]0.00 2.27 1 2.27 0.00 1.98 1 1.98
Q10366 pik1 Phosphatidylinositol 4-kinase pik1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pik1 PE=1 SV=1 - [PIK1_SCHPO]0.00 2.35 1 2.35 0.00 1.78 1 1.78
P87234 gyp3 GTPase-activating protein gyp3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=gyp3 PE=1 SV=1 - [GYP3_SCHPO]0.00 2.23 2 2.23 0.00 1.77 2 1.77
O60108 cbh2 CENP-B homolog protein 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cbh2 PE=3 SV=1 - [CBH2_SCHPO] 0.00 1.78 3 1.78 0.00 2.01 2 2.01
O94733 Unassigned Schizosaccharomyces specific protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC191.01 PE=4 SV=1 - [YQ61_SCHPO]0.00 1.66 1 1.66 0.00 2.07 1 2.07
O14076 mpp6 Nuclear exosome-associated RNA binding protein Mpp6 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPACUNK4.11c PE=1 SV=1 - [YEAB_SCHPO]0.00 1.91 1 1.91 0.00 1.69 2 1.69
Q9HGN7 sec63 Translocation protein sec63 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=sec63 PE=1 SV=1 - [SEC63_SCHPO]0.00 1.61 3 1.61 0.00 1.95 2 1.95
O59741 prt1 Transcription factor prt1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPBC530.05 PE=3 SV=2 - [YN25_SCHPO]0.00 1.82 2 1.82 0.00 1.72 1 1.72
Q76PC3 mme1 Mitochondrial magnesium ion transmembrane transporter Mme1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=SPCC1442.03 PE=3 SV=1 - [YQ73_SCHPO]0.00 1.85 1 1.85 0.00 1.68 1 1.68
Q10110 rrn3 RNA polymerase I-specific transcription initiation factor rrn3 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=rrn3 PE=3 SV=1 - [RRN3_SCHPO]0.00 1.85 1 1.85 0.00 1.63 1 1.63
Q9Y802 lsd1 ysine-specific histone demethylase 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lsd1 PE=1 SV=1 - [LSD1_SCHPO]0.00 1.66 3 1.66 0.00 1.70 1 1.70
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